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This report provides data and information to enable the assessment of the CSG Next programme 
in terms of results, vitality and viability:
1.  Results: how and to what extent have the objectives and ambitions of the CSG Next 
programme been realised? 
2.  Vitality: how and to what extent has CSG developed a distinctive profile for ELSA genomics 
research and societal interaction?
3.  Viability: how and under which conditions can and should the work of CSG be continued? 
Chapter 1 presents the context for an evaluation of the preliminary results, vitality and viability of 
the programme by means of a short history of the centre and an overview of the construction of 
the current programme (CSG Next) as well as its management and organisation. 
Results are presented in chapter 2 (scientific quality), chapter 3 (productivity) and chapter 5 
(valorisation). 
Moreover, CSG Next coordinates the public education and communication activities of the 
Netherlands Genomics Initiative. Therefore, chapter 4 presents the education and communication 
programme, which is an integrated part of the overall CSG Next programme. The ambition to 
combine academic research with societal valorisation, including education and communication, is 
an important part of the distinctive profile of CSG Next.
Based on the results of the CSG Next programme so far, the vitality of this profile is assessed in 
chapter 6, complemented by an analysis of the present strengths, weaknesses, opportunities and 
threats for the programme’s viability.
This report has 5 annexes. Annex 1 is the Business Plan 2008 - 2012; Annex 2 gives an account 
of CSG’s first periode (2004 - 2009). Annex 3 contains information about CSG’s research 
portfolio, and Annex 4 describes the output by CSG’s project leaders and researchers. Annex 5 
contains the 2008 - 2010 budget and spending.
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1Chapter 1Introduction to the Centre for Society and Genomics
1.1  The Centre for Society and 
 Genomics: a short history
[My life] happened to coincide with the most 
dramatic burst of knowledge in the whole history of 
mankind... Life itself has yielded its secrets, its central 
mechanisms have been unravelled in intimate detail 
and its history has been probed back to [its] origin... 
The lines quoted above were taken from an 
autobiographical retrospect by Nobel Prize 
laureate Christian de Duve entitled Life 
evolving (De Duve 2002, p. vii). They convey a 
conviction, voiced in countless similar documents 
as well, and ubiquitously present in journals such 
as Nature and Science, that we are witnessing a 
scientific revolution of breathtaking dimensions, 
the scope and impact of which is comparable 
to the one that so irreversibly transformed the 
processes of scientific knowledge production in 
the seventeenth century. In the life sciences, the 
revolution was inaugurated by the discovery of the 
structure of DNA by Watson and Crick in 1953 
and crowned by the completion of the sequencing 
of the human genome in 2003. Indeed, the 
sequencing of the genomes of an exponentially 
growing number of species is among its core 
activities.
It seems indisputable, that a similar and 
simultaneous process of transformation has 
affected our own areas of research as well. One 
of the characteristic features of this process is, 
that it has become increasingly difficult to identify 
or define our quickly evolving field. Traditional 
denominations in disciplinary terms (such as 
philosophy of science, science ethics, bioethics, 
sociology of science, etc.) increasingly gave way to 
what is generally regarded as a converging field that 
brings together experts, concepts and research 
tools coming from a broad range of disciplines. 
Roughly, this transformation process can be 
summarised as follows. In the 1970s the focus was 
on comprehensive critical assessments by single 
authors in the form of influential monographs 
addressing the major challenges entailed by 
technoscientific developments on a relatively high 
level of aggregation - such as for instance Ivan 
Illich’s Medical nemesis (1976) and Hans Jonas’s 
Das Prinzip Verantwortung (1979). Subsequently, 
in the 1980s and 1990s there was a process of 
professionalisation and institutionalisation in 
areas such as bioethics, policy studies, technology 
assessment and the like. During the first decade of 
the new millennium a novel view, a new approach 
gradually took shape. Usually, it was presented 
under headings such as “research into the ethical, 
legal and social issues or aspects of science”.1
This type of research has a number of important 
features. First of all, it is developed and 
conducted in close proximity to emerging life 
science areas, such as genomics, and in close 
interaction with the life scientists. Secondly, it 
tends to be anticipatory and forward-looking 
rather than retrospective in terms of temporal 
orientation, exploring and identifying emerging 
issues and concerns. Finally, it is developed and 
conducted in close interaction with a broad 
range of societal stakeholders. Rather than on 
dissemination of research outcomes, the focus is 
on involving stakeholders at a much earlier stage 
of the research, so that their views, concerns 
and expectations can be used as input for ELSA 
projects. Against this backdrop the Centre for 
Society and Genomics was established in 2004. 
1.  ELSI in the U.S. (notably in the context of the Human Genome Project), ELSA in the EU (notably in the context of Genomics 
programmes), GE3LS in Canada (Genome Canada). The existence, viability and future of the ELSA-acronym and approach are 
increasingly contested among researchers, as well as among managers and policy-makers in the field. CSG is also presently reconsidering 
the prominence of the term. For reasons of readability and clarity, however, it has largely been maintained in this report.
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Anticipatory research 
in proximity and 
in interaction with 
stakeholders
Why a Centre for Society and Genomics? The 
Netherlands Genomics Initiative, founded in 
2001, issued a call for so-called Genomics Centres 
of Excellence, in which it was stipulated that the 
plans of these Centres of Excellence should also 
contain a programme for societal research. The 
committee that reviewed the plans concluded 
that most centres had failed to do so – they 
mainly focussed on communication activities. 
Although there was already a programme on ‘The 
Societal Component of Genomics Research’ 
(funded by NWO, the Dutch research council), 
the committee deemed it necessary that societal 
research performed in close cooperation with the 
Centres of Excellence was essential, and that a 
national centre was the best way to organise this. 
So, in December 2002 a call was published 
by NGI, inviting experts in the field of ELSA 
research to submit proposals for setting up a 
Centre for Society and Genomics  (CSG). An 
expert committee chaired by George Gaskell 
(London School of Economics) assessed the 
proposals of three competing teams. On the basis 
of their written proposals in combination with 
face-to-face meetings with principal applicants, 
it was decided that the new centre was to be 
established at the Faculty of Science of the 
Radboud University Nijmegen. 
To those involved in setting up the CSG at 
the time, it was clear that they were part of an 
experiment and involved in developing a novel 
kind of organisation, virtually without precedent 
in the Netherlands. First of all, CSG was to be a 
national centre, responsible for developing and 
conducting a national programme of research by 
combining mass and focus. Until then, this type 
of research had been conducted through grant 
applications submitted in the context of open 
calls by departments or individual experts. As a 
national network did not yet exist, it had to be 
built through research. The idea was to assemble 
all the major players into one programme. 
Moreover, CSG emerged as a centre with a 
typical ELSA profile. First of all, research was to 
be conducted in close interaction with activities 
in the sphere of education, communication 
and societal interaction. Rather than being 
a centre with an outspoken and more or less 
established disciplinary identity, such as for 
instance Bioethics, STS or TA, the objective was 
to combine tools, insights and experiences from 
a broad range of relevant fields. Moreover, CSG 
was part of the Netherlands Genomics Network. 
Genomics Centres were both the targets of, and 
partners in research. Notably, CSG was expected 
to develop collaborations with the four Centres 
of Excellence that were the leading players in this 
network. 
As Hub Zwart (professor of philosophy, RU 
Nijmegen) was appointed as scientific director, 
he invited experts from five different universities, 
representing five different forms of expertise, 
to join the Core Group of the new centre. The 
budget amounted to e 4 mln. CSG’s mission, 
was to analyse, assess and improve the conditions 
for societal embedding of genomics. In four years 
time, a portfolio of 20 research projects (4 PhD’s 
and 16 postdocs) was developed, conducted at 
various universities throughout the Netherlands, 
in combination with activities in the sphere of 
education and communication, such as a public 
website. Annex 2 gives an account of the main 
results of the CSG I programme. 
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In 2006, 22 months after CSG had started, a 
first Mid-Term Review was organised by QANU 
(Quality Assurance Netherlands Universities) on 
behalf of NGI. A Mid-Term Review Committee 
was established, chaired by Prof. Dr. John Dupré 
(Egenis, University of Exeter) working on the 
basis of the Standard Evaluation Protocol. 
The most important recommendation of the 
MTR committee was that CSG should put 
more emphasis on further developing its unique 
branding: proximity to cutting-edge genomics 
research in combination with an interactive 
methodological profile and approach, resulting 
in project outcomes with a recognisable CSG 
imprint and having potential for establishing 
a distinctive character of our work also 
internationally. Building on this recommendation, 
the further development on our interactive 
research mode has become an important focus for 
management and research ever since. 
When in 2007 a sequel programme for genomics 
research in the Netherlands was launched 
by NGI, it was decided, on the basis of the 
midterm review 2006 and other assessments, 
that CSG should continue and that all these 
activities should be brought together into one 
comprehensive programme, combining mass 
and focus with visibility. CSG was to combine 
and coordinate all research, communication 
and education activities that were previously 
the responsibility of separate organisations 
(NGI itself, the Genomics Centres, the NWO 
programme, CSG). CSG’s total budget would be 
e 25 mln., roughly an increase of 25% compared 
to the budgets previously available. 
A Business Plan 2008-2012 was developed for 
CSG Next. CSG’s mission remained basically 
the same: to analyse (through conceptual and 
empirical research), assess (in a critical manner) 
and improve (through recommendations 
and interventions) the prospects for societal 
embedding of genomics, by aligning research 
and policy agenda’s and feeding (and improving 
the quality of) societal and policy-debates over 
genomics-related issues. The new programme 
should be a joint endeavour of all the other 
Centres of the NGI network (sixteen genomics 
partners in total), under the lead of CSG, and it 
was to entail collaborations with partners from 
society and industry as well. Moreover, research 
on the one hand and communication and societal 
interaction on the other were not seen as separate 
activities, but rather as closely connected, so 
that communication and interaction would 
provide input for research activities and vice 
versa. Interactive research can do more than 
produce reflections or afterthoughts concerning 
ethical, legal and social aspects of genomics. The 
proximity of ELSA research to the genomics 
research infrastructure allows for the study of 
ongoing and emergent developments, with results 
that can anticipate and affect the actual course 
that science and its applications (may) take. 
Moreover, in the business plan for CSG Next, 
communication was not merely considered as an 
additional activity, but also an item for scholarly 
analysis and experimentation.
 
CSG Next was to be led by a Management Team 
consisting of three directors, appointed at the 
Radboud University Nijmegen – Annemiek 
Mission: analyse,
 assess and improve the 
conditions for societal 
embedding of genomics
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Nelis (General Director, STS), Hub Zwart 
(Scientific Director, Philosophy of Science) 
and Gijs van der Starre (Managing Director, 
previously at NGI) – in collaboration with a 
Programme Committee consisting of six Principal 
Investigators representing important research 
groups at different universities as well as 
important disciplinary fields: Martina Cornel (VU 
University Medical Center, Community Genetics 
and Public Health Genomics), Michiel Korthals 
(Wageningen University, Bioethics), Patricia 
Osseweijer (Delft University, Biotechnology 
and Society & Science Communication), 
Dirk Stemerding (Innovation Studies, Twente 
University), Arend-Jan Waarlo (University 
of Utrecht, Science Education) and Guido de 
Wert (University of Maastricht, Bioethics).2 
The new plan was explicitly supported by all the 
Genomics Centres funded by NGI. Upon a review 
by international peers, the programme could be 
launched. The CSG Next programme started on  
1 January 2008. 
 
1.2  The programme of the Centre 
for Society and Genomics
Mission and objectives
The mission of CSG Next - to analyse, assess and 
improve the conditions for embedding genomics 
in society - has been translated into four main 
objectives:
-  Add to the academic body of knowledge about 
society-genomics relations
-  Strengthen the governance of genomics
-  Improve quality of public debate on genomics
-  Educate researchers, professionals and citizens 
to assess genomics at its value for society
While the first objective concerns the academic 
part of the mission (to analyse and assess), the 
latter three objectives are specifications of the 
societal part of the mission (to improve). On the 
basis of this mission, three research programmes 
were developed, presented in chapter 2:
1.  Genomics applications
2. Genomics agendas
3. Genomics education and communication
Business Plan
CSG’s programme was laid down in a Business 
Plan 2008 – 2012, approved by NGI in September 
2007. Projects were described in concise formats 
and had to be developed into full proposals. Some 
12% of the budget was held in reserve. This 
reservation is mainly used for so-called building 
block projects (see chapter 6) and a valorisation 
fund (see chapter 5). 
Activities
CSG Next combines academic activities (the 
research programmes and network activities) with 
societal activities (dialogue, communication and 
education). Typical for the profile of CSG Next 
is the tendency to integrate societal activities 
in research activities, and vice versa with a 
focus on stakeholder involvement and agenda 
setting. Besides a substantial communication and 
education programme (presented in chapter 4), 
many dialogue, communication and education 
activities are organised either as part of or in 
close collaboration with research activities. The 
combination of research with interaction aims at 
the production of relevant knowledge that can 
also be used by others than academic peers. 
2.  In 2009, Dirk Stemerding was succeeded by Jacqueline Broerse (Free University of Amsterdam, Innovation Studies and Public 
Engagement Research). In 2010, as general director Annemiek Nelis left CSG, Maud Radstake (Research and Interaction) and Frans van 
Dam (Communication Officer) have joined the Management Team. 
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1to understand, assess and improve the conditions for embedding genomics in society
Research
programmes
1  Genomics 
applications
2  Genomics agendas
3  Genomics 
education and 
communication
Stakeholders 
(patients, consumers, 
professionals, industry)
target groups
activities
objectives
Mission
Public policy General public Students
network activities
-  International 
conferences
-  Workshops and 
seminars
- Visiting professors
- EU projects
Dialogue
- Conferences
-  Panel genomics 
agenda
-  Discussions, debates
- Policy events
- Policy briefings
Communication
-  Public website 
allesoverDNA.nl
-  Societal publications
- Public events
- Exhibitions
-  Stakeholder meetings
-  Corporate magazine
education
-  Education programmes 
secondary schools
-  DNA-labs on the road
-  Postgraduate training
-  School competition 
Imagine…
-  Societal education for 
junior life scientists
Strengthen the
governance of
genomics
add to academic body 
of knowledge about 
society-genomics 
relations
educate researchers, 
professionals and 
citizens to assess 
genomics at its value 
for society
improve quality of 
public debate on 
genomics
(Genomics)
Reseachers
interactive 
research
Figure 1: construction of the CSG Next programme
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Budget
All research projects include budget and time for 
communication and interaction. CSG Next has 
a budget of e 25 mln, of which app. 70% is spent 
on research projects, 20% on communication 
and education activities and 10% on corporate 
communication and general management.
Unlike other NGI Centres, CSG has no 
matching obligation. However, CSG has been 
able to attract matching funds in its so-called 
building block projects. These building blocks 
concern research projects with partners (mostly 
large research consortia), which CSG deems of 
strategic importance in view of a possible CSG 
3 (after 2013). They provide 25% or more of the 
project costs. So far six building blocks have been 
developed, with a matching of some e450.000 
(cash or in kind). 
Target groups
General target groups for all activities of CSG 
Next are:
-  (genomics) researchers
-  stakeholders (patients’ and consumers’ 
organisations, professional organisations, 
industry)
-  public policy
-  the general public
-  students (secondary and higher education)
Members of those target groups can be involved as 
(prospective) partners, users or beneficiaries of the 
various activities and their results. 
The NGI genomics centres play an important 
role as partners and target groups of the CSG 
Next programme. Research projects involve 
interactions with virtually all the centres that 
are part of the NGI genomics network (see figure 
3). Interactions with genomics researchers range 
from participation in supervisory committees 
and expert workshops to co-authorship, research 
interviews and education activities. The value of 
CSG Next for the other NGI centres is discussed 
in the paragraph on relevance in chapter 2. The 
value of the programme for societal target groups 
is discussed in chapter 5 (valorisation). 
Approach: interactive research
The mission and construction of the CSG 
Next programme required the development of a 
particular style of societal research, combining 
academic knowledge production and analysis 
with communication and education activities 
and collaborations with scientists and societal 
Self-evaluation 2008-2010
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Genomics Centres
Figure 3: Centres of the Netherlands Genomics Initiative
Figure 2: Budget Centre for Society and Genomics
corporate communication 
and general management
70% 
communication and 
education activities20%
10%
research
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target groups. Besides as input for further research, 
interactive events and trajectories function as 
test-beds for the impact and relevance of the 
research programme. In figure 1, this combination 
of research and interaction is presented as 
‘interactive research’. 
This combination occurs at the programme level, 
at the level of the three research programmes 
and at the level of individual projects. Focus on 
societal interaction is an integrated part of all 
research proposals that have been accepted for 
the CSG Next programme. The guidelines for 
developing interaction provided by the CSG 
management include instructions to address the 
relevance of the project for specific target groups 
and a plan for the actual involvement of those 
groups over the course of the research project. 
CSG’s interactive approach has been the object 
of research in CSG I and CSG Next as well as in 
international publications and collaborations3. 
The results of these research activities have 
informed the current strategies for research 
management and valorisation of CSG. 
1.3  Management and organisation
The CSG programme is managed by the man-
agement team based at the Institute for Science, 
Innovation and Society, Faculty of Science at the 
Radboud University Nijmegen. The management 
team is led by prof Hub Zwart, scientific direc-
tor, and further consists of Gijs van der Starre 
(managing director), dr Maud Radstake (man-
ager research and dialogue) and Frans van Dam 
(manager communications). Together with six 
principal investigators they form the Programme 
Committee. Tasks within the Programme Com-
mittee are divided along the three programmes of 
CSG: Genomics Applications, Genomics Agen-
da’s, Genomics Education and Communication. 
csg researcher 
Koen Dortmans 
in action1
3.  Including an EMBO Reports Science & Society Series on ‘convergence research’ based on an international workshop organised by dr 
Peter Stegmaier as part of his CSG-I research project; and a workshop with international invited speakers to be organised in Graz, Austria 
in June 2011, by dr Bernhard Wieser (IFZ, Graz/ GEN-AU) and dr Maud Radstake (Radboud University Nijmegen/ CSG).
14
1
For each line, a member of the CSG management 
team and two principal investigators are responsi-
ble for developing, monitoring and supporting the 
research projects involved. 
Three principal investigators have direct links to 
an NGI Genomics Centre:
-  Prof Martina Cornel is connected to the 
Centre for Medical Systems Biology
-  Prof Arend Jan Waarlo is connected to the 
Cancer Genomics Consortium
-  Prof Patricia Osseweijer is connected to the 
Kluyver Centre for Genomics of Industrial 
Fermentation
Research proposals are assessed by the 
International Scientific Advisory Board. 
Composition:
-  Prof George Gaskell, London School of 
Economics, UK (chair) 
-  Dr Roger Busch, (formerly) Ethik-Institut 
Technik-Theologie-Naturwissenschaften, 
München, Germany
-  Prof Anne Cambon-Thomsen, INSERM 
Toulouse, France
-  Prof Ruth Chadwick, CESAGen, Cardiff, UK
-  Prof Herbert Gottweis, Department of 
Political Sciences, Universität Wien, Austria
The Scientific Advisory Board has met twice in 
2008, twice in 2009 and once in 2010. 
An Advisory Board focusing on strategy and 
embedding meets three times a year and consists 
of:
-  Dr Diederik Zijderveld, Director of Knowledge 
at TNO Quality of Life, former director of the 
Netherlands Genomics Initiative
-  Prof Fons Werrij, former chair programme 
committee ‘The Societal Component of 
Genomics research’
-  Michiel Buchel, general director science 
center NEMO, Amsterdam
-  Prof Rob Hoppe, professor of Policy and 
Knowledge at University of Twente
-  Dr Anton Franken,Vice-President of the 
Executive Board, Radboud University 
Nijmegen
15
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Prof Michiel Korthals
Dr Jacqueline Broerse Prof arend Jan WaarloProf Guido de Wert
Prof Patricia osseweijerProf Martina Cornel
Prof Hub Zwart Gijs van der Starre Dr Maud Radstake frans van Dam
CSG Management
Genomics applications
Principal investigators
Genomics agendas
Principal investigators
Genomics Communication
and education
Principal investigators
CSG’s Programme Committee 
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2.1  System for productivity and quality 
assurance
In CSG’s Business Plan (April 2007) the three 
programmes (Genomics applications, Genomics 
Agendas, Communication and education) and their 
research projects were presented in a concise manner. 
The procedure CSG employs for developing and 
processing research proposals contains the following 
steps:
-  A standard format for full proposals is used
-  Project leaders are invited to elaborate the project 
into a full proposal. A principal investigator is 
appointed for support and recommendation on 
aspects of quality and relevance.
-  A full proposal is then discussed with the 
management of the programme involved. When 
the management is convinced that the proposal 
meets the conditions as set out in the proposal 
format, the proposal is presented in the Programme 
Committee
-  The Programme Committee then decides if 
the project will be put before the International 
Scientific Advisory Board (ISAB). 
-  If so, the ISAB can advise that:
 A. the project can go ahead
 B.  there are some questions that need to be 
addressed. If done satisfactorily (this to be 
judged by the Scientific Director of CSG), the 
project can go ahead
 C.  the proposal is rejected and has to be 
resubmitted
A project can only be resubmitted once.
The four ‘large’ NGI genomics centres (Centre for 
Medical Systems Biology, Centre for Biosystems 
Genomics, Cancer Genomics Centre, Kluyver 
Centre for Genomics of Industrial Fermentation) 
occupy a special place in CSG’s programme. They all 
have a share of e 2 mln. in the programme, roughly 
divided into 75% for research projects and 25% for 
communication and education projects. All projects 
are endorsed by the management of these centres. 
Some centres have the research projects that are 
part of CSG’s programme also reviewed by their own 
scientific advisory board; this has never led to different 
outcomes compared to reviews by CSG’s Scientific 
Advisory Board. 
CSG has several instruments to support and monitor 
the progress of its research projects. 
-  Every project is visited once a year by the principal 
investigator in charge. General progress and 
bottlenecks are discussed.
-  At least once a year CSG organises a two day 
retreat for all researchers and project leaders. 
The main objectives are community building 
and discussing various topics related to the CSG 
programme (such as valorisation, interaction with 
stakeholders). These researchers’ days are highly 
valued by the participants. The attendance is more 
than 90%. 
-  For each programme, meetings are organised 
in which manuscripts (generally drafts for peer 
reviewed articles) are presented and discussed. 
-  Each project reports in writing once a year 
(execution of the project proposal, budgets). CSG 
uses the project reports for its annual report to the 
Netherlands Genomics Initiative.
All in all, this system works rather well. It provides 
the opportunity to strengthen coherence between 
individual projects. On the other hand, instruments 
to really influence progress and quality of individual 
research projects at various universities (notably for 
projects that are not led by CSG management or 
principal investigators) are limited. 
2.2 Scientific progress
This section presents and analyses the research results 
for each of the three programmes: 
1.  Genomics applications; 
Chapter 2
Quality and scientific relevance
218
Self-evaluation 2008-2010
2.  Genomics agenda; and  
3.  Communication and education. 
A full description of all the research projects is 
included in Annex 3. 
PRoGRaMMe 1  
GENOMICS APPLICATIONS
Management
Dr Maud Radstake
Principal investigators
Prof Guido de Wert
Prof Martina Cornel
number of projects 18
number of PhDs 12
number of postdocs 6
number of junior researchers 1
number of vacancies 1
Mission and objectives
Programme 1 addresses conditions and prospects 
for the application and translation of genomics 
in various practices. Its projects not only aim 
to understand and improve the conditions 
for translating genomics but also assess the 
feasibility, viability and desirability of particular 
applications. Connecting the critical evaluation 
of claims, hopes and expectations with the 
constructive assessment of hurdles, opportunities 
and challenges, programme 1 aims to contribute 
to the governance of the translation of genomics 
knowledge and technologies into socially robust 
applications.
Main themes
The two themes that structured programme I 
in the business plan for CSG Next (changing 
practices and policies; identity and behaviour) 
have developed into a thematic organisation of 
the programme along three lines:
1.  Translating genomics in clinical care and 
public health 
2.  Assessing the value of genomics applications 
for life science research
3.  Embedding genomics in agricultural and 
industrial biotechnology
Within this thematic focus, the programme 
covers a variety of practices and topics and 
features multiple conceptual and methodological 
frames used for research. Projects study genomics 
applications not only in medical scientific 
research fields and infrastructures (including 
virology and toxicology) but also in agricultural 
and industrial biotechnology. 
The projects on public health, screening and 
testing continue research lines that have been 
developed in previous projects performed as part 
of the first CSG programme or by participating 
groups. Programme 1 hosts and connects several 
complementary and experienced research groups 
in the field of genetics, genomics and health. 
Programme I uses a diversity of approaches. Some 
projects take an analytical or reflective approach, 
using methods and insights from law, anthropology, 
sociology, ethics and philosophy, providing a 
critical balance to projects which are primarily 
implementation-oriented, aiming to overcome 
hurdles and challenges for particular applications 
(mostly for health care or public health). The 
practical orientation of the latter type of projects, 
in turn, offers translational perspectives for the 
former set of analysis-oriented projects. 
Academic value
Most projects in Programme 1 are on schedule 
in terms of academic output, taking into 
consideration that some projects have only 
started less than a year ago. Research results have 
recently been published in a variety of academic 
journals, including highly valued journals such 
as Nature Reviews Genetics (impact factor (IF) 
27.8), Diabetes Care (IF 7.3), American Journal 
19
of Bioethics (IF 4.0), European Journal of Human 
Genetics (IF 3.6), BMC Public Health (IF 2.2) and 
Public Health Genomics (IF 1.3). 
Programme 1 starts from the idea that answering 
the question whether and how genomics 
knowledge and technology can be applied, 
requires a thorough analysis and understanding 
of current societal practices on the basis of 
interdisciplinary collaboration. This goes for the 
existing practices where knowledge or technology 
will be applied, as well as for discussions about 
(potentially conflicting) possibilities and purposes 
of future applications. Projects in the programme 
that are primarily driven by the aim to be 
beneficial or relevant to society (e.g. improve 
health care or food production), use academic 
methods and knowledge for that purpose. Projects 
primarily driven by the desire to enrich academic 
discussions, use analyses of new technologies 
and knowledge practices for that purpose. It is 
rather uncommon for projects with such different 
orientations to be connected in one research 
programme. The combination of projects in 
programme 1 renders common self-evidences 
and familiar notions like risk, nature, health 
and individual choice less obvious. In light of 
the complexities and challenges faced in the 
governance of genomics applications, therefore, 
the wide-ranging composition of the programme 
has proven to be a major strength. In Annex 
3, an overview of all projects is included. The 
highlights include: 
CluSteR 1
Translating genomics in clinical care and 
public health 
-  Registration of ethnicity, often considered 
to be discriminatory in the Netherlands, 
is increasingly considered by health care 
professionals as a condition for good clinical 
care that may decrease health inequalities 
between members of ethnic groups (project 
Neonatal screening and beyond: integration 
of hereditary hemoglobinopathy screening into 
primary care); 
-  Classical distinctions in ethics and policy 
between diagnosis and screening and between 
reproductive and non-reproductive screening 
“communication with parents about false-positive 
results from heel-pricks can and must be improved”
 carolien Boelen, csg researcher and pediatrician lumc
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become blurred by the introduction of whole 
genome analysis (projects Governance of 
preventive genomics); 
-  The normative assessment of genomic 
predictive testing for antisocial behaviour in 
children cannot meaningfully be distinguished 
from the assessment of normative issues in 
non-genomics (especially psychological) 
predictive testing in this field, since the 
application of both types of testing will be 
closely related and normative issues for both 
types of testing are similarly complex (project 
The promise and pitfalls of the genomics of 
antisocial behaviour for prevention); 
-  The Dutch Act on Population Screening is 
not in line with European law (project Large 
scale applications of genomics in the field of 
predictive medicine in the Netherlands: the role of 
the law).
CluSteR 2
Assessing the value and governance of 
genomics applications for life science 
research 
-  Paradigmatic differences between 
toxicogenomics and more ‘traditional’ 
alternatives for the use of animals in research 
could interfere with decision-making on 
funding for research on alternatives for animal 
testing (project Toxicogenomics: beyond the 
golden standard?);  
-  Current reviewing practices by academic 
ethical review boards are not able to address 
some critical issues for biobank governance, 
such as the entanglement of diagnostic and 
research activities in biobanking and the 
political nature of decision-making on tissue 
and data use in relation to priorities and 
strategies for biomedical research (project 
Biobanks and governance); 
-  The position of virology is paradoxical: it 
aims at protecting people from viral threats 
and simultaneously increases feelings of fear 
in society (project Between uncertainty and 
catastrophy: Viral genomics as a postnormal 
science); 
2
“For influenza there are no plausible 
scenarios, only worst-case scenarios”
Ab Osterhaus, virologist at a csg debate on the 
Mexican Flu, Nijmegen, september 2009
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CluSteR 3
Embedding genomics in agricultural and 
industrial biotechnology
-  The assessment of perceptions of a particular 
breeding method and its agricultural 
application as more or less natural, requires 
an ethical model that takes into account the 
balance between cultural, technological and 
ecological values (project Ethical debates on 
naturalness); 
-  The method of ‘midstream modulation’ has 
been adapted and proven to be successful 
in the interactive assessment of relevant 
social and ethical issues with biotechnology 
researchers in the context of ‘for profit’ 
research (project Hurdles in innovation)
Besides presenting valuable contributions to 
ongoing academic and societal discussions on 
genomics in society in themselves, this overview 
of results indicates how the aim of programme 1 
to be more than the sum of its parts has worked 
out so far. While preserving valuable conceptual 
and methodological diversity, the programme 
connects researchers and research groups by 
providing a platform for exchange, discussion and 
learning. One of the main aims for the second half 
of the programme is to stimulate the translation 
of ongoing and intended collective learning 
processes into actual collaborative results in the 
form of academic as well as societal output.
PRoGRaMMe 2
GenoMiCS aGenDa
Management
Prof Hub Zwart
Principal investigators
Dr Jaqueline Broerse
Prof Michiel Korthals
number of projects 16
number of PhDs 7
number of postdocs 7
number of junior researchers
number of vacancies 3
Mission and objectives
Programme 2 addresses the ongoing 
Transformations of Knowledge Production and 
Research Agendas that are part of the current 
revolution as described in chapter 1: notably 
the emergence of big science in life sciences 
research, with the sequencing of genomes as 
its core activity. This is closely connected with 
the anticipatory nature of CSG research. In 
addition to assessing the pros and cons of specific 
applications, the programme studies the up-
stream (‘internal’) scientific developments that 
will eventually result in such applications, in 
order to determine to what extent an alignment 
of scientific and societal trends and agendas is 
feasible. The agenda of genomics research is 
shaped by a complex set of factors such as funding 
possibilities (e.g. e 600 mln. of funding for 
genomics research in the Netherlands between 
2002 and 2012), the organisation of knowledge 
production (e.g. the emergence of new fields such 
as bio-informatics), institutional frameworks 
(bans on certain forms of research and bonuses 
for others), public opinion (e.g. the GM-debate) 
and the role of promises and expectations in the 
public domain. This programme focuses on the 
genomics agenda: how is this agenda shaped and 
how can it be made more ‘socially robust’?
Main themes
Whereas in the business plan two research strands 
were distinguished within this programme, the 
initial scheme has developed into a thematic 
clustering of projects around three topics:
1. Intellectual Property Rights and global justice
2. Innovation pathways
3. Genomics and the ecocentric turn
22
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This shift towards three thematic clusters 
constitutes a ‘natural’ development as it were. 
As research progressed and exchanges in the 
context of researchers’ meetings intensified, these 
emerged as point of convergence, not only in our 
research and our debates, but also because of their 
relevance to the outside world. 
Academic value
CluSteR 1
Intellectual Property Rights (IPR) and 
global justice
The current IPR regime is facing a major crisis. 
It is regarded by many as expensive, cumbersome 
and inefficient and does not seem to realise 
its goals. It increasingly seems to become an 
obstacle rather than a facilitator of innovation. 
The projects assembled under this heading: (a) 
analyse the causes and dynamics of the current 
crisis, notably in the field of agricultural and 
industrial genomics; (b) assess the current crisis 
of the IP system from a normative and conceptual 
perspective and (c) contribute to developing a set 
of possible solutions. This is done by developing 
alternative schemes along the lines of open-
source strategies, common knowledge pools and 
benefit-sharing models, not as a replacement, 
but rather as a complementary set of tools for 
innovative governance and regulation on a global 
level. In other words, the converging message of 
the projects assembled under this heading is the 
effort to develop a more fair and pluriform system. 
Rather than strengthening the divide between 
‘owners’ versus ‘users’ of technologies, we aim to 
contribute to the development of a worldwide IPR 
regime from which all stakeholders may benefit. 
This requires, first of all, a shift towards a more 
globally oriented policies perspective for science 
and innovation. And this implies a break with 
nationally oriented science & innovation policies 
and valorisation that have dominated the research 
landscape so far. Furthermore, the projects show 
that important and valuable forms of valorisation 
remain invisible due to rather narrow framings 
of what counts as valorisation. In other words, 
although various forms of useful and meaningful 
knowledge are produced, a framing of valorisation 
solely in terms of patents does not allow us to 
see or develop the full societal potential of the 
research streams involved. 
Notwithstanding the emphasis in contemporary 
discourse on the globalisation of cultural, 
scientific and economic developments, IPR 
schemes often reinforce attitudes of protectionism, 
notably by framing the issue in terms of East 
(growing economies in Asia) versus West (US 
and EU). This seems at odds with the spirit of 
scientific and technological internationalism of 
the early post-war years, symbolised for instance 
by the founding of UNESCO, which seemed to 
envision a much more generous, open-minded 
attitude oriented on collaboration and innovation 
than the current tendency to narrow societal 
value to IP. Yet, behind the scenes of apparently 
‘technical’ discussions, clashes of diverging world-
views on the global arena often play a prominent 
role. These findings entail important messages, 
for scientists, universities, research institutes, and 
for research policy, but also for funding agencies, 
including NGI and similar future initiatives.
Projects involved: How to overcome the 10/90 
gap in genomics research agendas?; Genomics, 
Intellectual Property Regime and Global Justice; 
Towards a participatory, commons-based innovation 
in the agrotech industry; The promise of Open Source 
Genomics.
CluSteR 2
Innovation pathways 
As was already indicated above, the impact of 
genomics should not be solely defined in terms of 
genomics ‘applications’. Indeed, one could state 
that the most significant impact of genomics 
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research so far is the extent to which it has 
irreversibly affected and altered the way in which 
research in the life sciences is done. Notably, 
CSG’s research shows how genomics contributed 
to transforming biology (and even the life sciences 
more broadly) into an information science, with 
all the opportunities as well as bottlenecks this 
entails (project: Bioinformation and identity). 
On the other hand, the research shows that 
genomics is still very much a laboratory term, 
a basic approach, more useful and prevalent in 
some areas than in others. Whereas in some 
branches of applied research genomics has become 
a well-established part of the tool-box, clearly 
affecting the type of research questions that are 
developed, there are many other forms of applied 
research, notably in the biomedical fields, such as 
asthma or Alzheimer research for instance, where 
researchers hardly define their work in terms of 
genomics at all. A similar case is education, where 
neurogenomics findings hardly play a role at all so 
far. The research in this area increasingly focuses 
on the question how to explain the lack of added 
value in such areas. Two provisional answers 
have arisen so far. One is that many applied fields 
are problem-oriented rather than innovation-
oriented. To put it simply: the focus is on patients 
and students rather than on databases. Another 
answer is that we have to broaden our search-
light so as to include bioclinical hybrids that 
have important genomics components, are or can 
become highly relevant to patients and clinicians, 
but are often not recognised or identified as 
genomics results.
Somewhat at odds perhaps with expectations 
in the past, genomics research has had more 
impact on research agendas in industrial settings. 
One project (Designing good food) studies the 
way ‘society’ enters industrial laboratories and 
co-shapes the production of food products. 
Societal input is most notable in the production 
of normative claims concerning food products 
(e.g. health, sustainability, enhancement or 
personalisation of food) of R&D departments. 
A project focussing on the ‘food versus fuel 
debate’, however, has found that international 
policy and ethical debates on biofuels have 
csg researcher Bart Penders 
at Unilever Research 2
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“There is a gap between the claims
of ecogenomics and actual research”
csg researcher sanne van der Hout
2
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become increasingly deadlocked due to a clash of 
worldviews as a backdrop to a variety of disputes 
on programmatic focus and funding strategies for 
research. The challenge, according to the project, 
is not to accept this and to develop novel ways to 
engage stakeholders in deliberative dialogue.
One way of stimulating a reflection among 
(future) life sciences researchers on the current 
evolution and future prospects of genomics 
knowledge is through the use of genomics novels 
as a special sub-genre within the field of science 
novels. The project Genomics novels as test-beds 
for genomics futures focuses not on how genomics 
novels articulate ‘public perceptions’ of genomics 
(as is usually done), but rather on how such novels 
(dealing with genes, DNA, mutations, genomes 
and genomics laboratories) help us to reflect on 
the philosophical and societal dimensions of 
emerging research fields. They provide us with 
literary windows into genomics laboratories. 
Often, these novels actively engage in scientific 
and epistemological debates on the nature and 
prospects of genomics and related fields. They 
focus not only on the ethical issues in a narrow 
sense, but also on how genomics is affecting our 
views on the history and future of life in general 
and of human existence in particular. Notably, the 
project builds on the idea that genomics novels 
can be seen as experiments exploring and testing 
various societal scenarios for genomics. 
CluSteR 3
Genomics and the ecocentric turn
Initially, the focus of the genomics revolution and 
of the promises and expectation associated with 
it, were primarily oriented towards the health 
domain. A number of CSG projects, however, 
focuses (in an anticipatory manner) on the 
societal benefits and prospects involved in some 
of the other, more recent branches of genomics 
research, notably industrial and ecological 
genomics. Although these developments may 
have relevance for health issues as well (in terms 
of novel components and ingredients for food, 
pharmaceuticals, etc), its promises predominantly 
are situated in efforts to contribute to more 
sustainable forms of agricultural and industrial 
production and eventually to the advent of a 
more bio-based economy. Thus, the increasingly 
overlapping fields of industrial and ecological 
genomics should not be seen as one particular 
branch or segment of genomics research among 
many others, but rather as a possible future for 
genomics research as such, in combination with 
emerging areas of research such as systems biology 
and synthetic biology.
Yet, notwithstanding the overall optimism 
that pervades current discourse on bio-based 
industrial developments, there is some reason 
for scepticism as well. First of all, there often is 
a gap between claims made about ecogenomics 
and industrial genomics in programmatic and 
strategic documents on the one hand and the 
research that is actually performed under this 
label on the other (project The societal profile of 
ecogenomics). It is often claimed for instance that 
ecogenomics through its focus on ecosystems 
and complexity will further a nature-friendly 
orientation in life science. By taking nature’s 
own resources and processes as a starting point, 
ecogenomics could play an important role in 
combating the environmental crisis. In practice, 
however, many ecogenomics research trajectories 
still seem to follow reductionist and engineering 
pathways more oriented towards manipulating and 
exploiting than towards ‘understanding’ nature. 
Yet, by taking its own potential seriously, the 
role of ecogenomics in combating environmental 
problems through sustainable biotechnologies is 
still a viable possibility for the future.
The focus of our research is not only on 
sustainable exploitation of biosystems already 
in use, but also of ecosystems that are open 
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to research through the novel tool-boxes of 
genomics such as highly vulnerable deep-sea 
ecosystems (Bioprospecting in the genomics era: 
exploring and assessing the normative issues). CSG 
explores the opportunities and risks involved in 
this development, outlining important issues for 
regulatory action on a global level. Finally, we 
assess the ‘cultural relevance’ of genomics, i.e. the 
extent to which genomics has transformed our 
view of life, nature and human history. 
PRoGRaMMe 3
CoMMuniCation anD eDuCation
Management
Gijs van der Starre 
Principal investigators
Prof Patricia Osseweijer
Prof Arend Jan Waarlo
number of projects 10
number of PhDs 8
number of postdocs 3
number of junior researchers 1
number of vacancies 1
Mission and objectives
The mission of programme 3 is to understand 
and improve interaction, communication and 
education for all actors that have a stake in 
genomics. This is done with an eye on a societal 
debate of high quality and quantity, and a 
robust embedding of genomics in society and 
of society in genomics. Programme 3 contains 
research projects as well as the major part of our 
communication and education activities. The 
latter will be described in chapter 4. A large 
part of the research projects in programme 3 is 
connected with communication and education 
activities. The analysis presented in this chapter 
only regards the research projects. 
Main themes
The two leading themes for the programme as 
indicated in the CSG Next business plan (new 
forms of public interaction; education and 
expertise) have been made operational in three 
core themes:
1. Empowering students in secondary education
2. Experts in public interaction
3. Improving dialogue and interaction
Since the 1990s, research about public debate 
on biotechnology, genetics and genomics has 
increasingly focused on the possibilities to 
engage citizens not merely with the eventual 
applications of new technologies (‘downstream’), 
but also with the development of science and 
technology itself (‘upstream’). Primary object of 
research and subsequent intervention has been 
the general public: citizens who do not have an 
immediate stake in the developments at hand, 
yet are likely to be affected by such developments 
or their results. Reasons to involve the general 
public include accountability (‘people have the 
right to know what public money is spent on’), 
public trust in science and acceptance of new 
technologies, and the equipment of citizens with 
the necessary knowledge to make their own 
choices. 
Public awareness of genomics is likely to be 
higher as research and applications touch 
upon people’s daily lives. For more distant 
developments like industrial biotechnology or 
plant genomics (projects: The value of emotions 
for triggering an articulated public-expert interaction 
for sustainability and Psychological positioning of 
communication on plant genomics: the role of the 
psychological context and mode of thought), when 
it is not yet clear which publics are likely to be 
affected, the general public remains the primary 
object for research and intervention. Yet in line 
with general developments in the field of public 
communication, education and engagement, most 
projects and activities in programme 3 target 
particular publics, that is collectives of people 
likely to be affected by (potential) applications of 
genomics knowledge and technology in a similar 
manner.
The first thematic focus in programme 3 is on 
students in secondary education, being the 
‘citizens of the future’. The DNA-labs on the Road 
are an outreach activity of genomics centres to 
bring secondary school students in contact with 
genomics techniques and to raise awareness about 
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their personal and societal impact, e.g. the issue of 
genetic testing. The research projects build on this 
and on another outreach activity, the Imagine…. 
school competition, and ultimately aim to preserve 
their success through rethinking science curricula 
and doing evaluation and design research. This 
research fits well within the current context-based 
science education movement to make science 
education more relevant to students and society. 
Up to now uncertainty and complexity have been 
identified as key concepts of the genomics era. 
These concepts refer to science as well as to issues 
people are being confronted with.
 A main difficulty for explaining cellular 
processes by molecular interactions is the lack 
of a framework for reasoning about complex 
systems that can help students to understand 
how cellular phenomena can emerge from 
the interaction of macromolecules. Such a 
framework, which includes visuals, has been 
developed by analysing the goals and strategies 
in molecular biology research. An educational 
approach informed by this framework is now 
being tested in classroom practice. The research 
findings have been discussed in two international, 
multidisciplinary workshops (2008 and 2010) and 
will finally be presented as curriculum proposals 
in a concluding national teacher conference in 
2012. The Imagine… school competition, which 
generates a great variety of projects, has a two-
fold aim: education and societal communication. 
The educational research that accompanies 
this education activity, focuses on framing this 
outreach activity within the junior thesis, i.e. a 
common academic research and writing project 
“The dna-labs on the 
Road are a direct way to 
innovate genomics education 
in secondary schools”
Dirk Jan Boerwinkel, uu
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for juniors in upper secondary schools. However, 
not much seems to have been published about 
the junior thesis, so a more detailed study 
is indicated to enable full utilisation of its 
educational potential. Some potential critical 
factors for the success of Imagine…. have been 
identified in interviews. These explorative 
research activities will be followed by establishing 
a theoretical framework for the Imagine…. school 
competition to enable the measurement of the 
intended learning outcomes. All three projects 
are on schedule. (projects: Towards a strategy for 
embedding genomics literacy in science education; 
Educating for visual literacy in a genomics world: 
fostering imagery of cellular and molecular dynamics 
in science education; Assessing and understanding 
the impact of education and communication in life 
sciences).
The second thematic focus is on experts in 
public interaction. Public debate and interaction 
do not merely involve citizens. Scientists and 
other professional experts also have their roles 
to play. They are pivotal in the definition 
and implementation of agendas for research 
and applications. Programme 3 explicitly 
acknowledges this and hosts a number of projects 
that focus on experts’ views on and experiences 
with public interaction. Better understanding 
the role of experts enables their engagement in 
mutually beneficial interactions with publics. 
Empirical research on experts’ attitudes and 
behaviour in various public interaction settings 
has revealed that experts implicitly or explicitly 
hold stubborn attitudes towards lay publics and 
behave stereotypically. So there is a discrepancy 
between theory and practice. Later on these 
empirical findings will be fed into workshops so 
as to promote self-reflexive learning of (future) 
experts and to explore together alternatives for 
establishing open communication. (projects Doing 
Dialogue and DNA: how to articulate societal issues 
for genomics research agendas; Defining expertise 
and citizenship: on the interactional dynamics of 
expert citizen expectations in plant genomics research; 
Psychological positioning of communication on 
plant genomics: the role of the psychological context 
and mode of thought; Distributed expertise in plant 
genomics; Developing training in genetics/ genomics 
for primary health care workers).
The third core theme, dialogue, features in a 
number of projects, including those on secondary 
education and the role of experts. The notion of 
dialogue has increasingly found its way into policy 
and public discourse on science communication, 
education and technology assessment. It 
commonly refers to formal communication and 
interaction and to processes of collective and 
mutual learning by stakeholders, publics and 
scientists. In programme 3, it is also used to 
describe informal interactions between those 
actors and to refer to interactions between 
scientists, teachers and students or between 
companies, consumers and social scientists. 
Because of various modes and forms, what 
dialogue means can never be taken for granted. 
That is why it presents a distinct theme for 
programme 3. A sub-project in the project Doing 
Dialogue expands the notion of dialogue to the 
role of ELSA genomics researchers themselves. 
CSG-projects are characterised by high levels 
of interaction with their research objects. An 
empirically-informed notion of dialogue can assist 
researchers in shaping interaction in the frame of 
Include citizens for reasons 
of accountability, public 
trust in science and citizens’ 
empowerment
Self-evaluation 2008-2010
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their own project, improving its empirical validity 
as well as its societal value.
Academic value 
Several projects have a strong practical focus, 
especially those that are directly connected to 
the communication and education activities such 
as the DNA-labs on the Road and Imagine… 
However, those and other projects also contribute 
to academic bodies of knowledge in the fields 
of science communication, science education, 
social psychology, philosophy and science 
and technology studies. All projects take an 
empirical approach: researchers enter classrooms, 
labs, research meetings, and public events. 
Besides increasing the understanding of roles 
and strategies in various modes of education, 
communication and public interaction, for some 
projects their empirical research also opens up 
spaces for targeted interventions. Vice versa, 
interventions in education, communication and 
dialogue practices contribute to the knowledge 
about the mechanisms at work.
The academic output of programme 3 is slowly 
starting to take up. The projects that are carried 
out by more experienced researchers (who often 
can build on their previous CSG projects) show 
a steady stream of output. Most PhD researchers 
are now writing or submitting their first articles 
or chapters. Highlights of programme 3 so far 
include:
CluSteR 1
Empowering students in secondary 
education
-  Existing methods and materials used in science 
education foster a deterministic notion and 
image of genomics information (projects 
Towards a strategy for embedding Genomics 
literacy in science education; Educating for visual 
literacy in a genomics world: fostering imagery 
of cellular and molecular dynamics in science 
education).
-  The DNA-labs on the Road (see chapter 
4) are a direct way to innovate genomics 
education in secondary schools (project 
Towards a strategy for embedding genomics 
literacy in science education).
-  Novel approaches that aim to address societal 
issues in science such as the Imagine… project 
attract more girls than other science projects 
(projects Towards a strategy for embedding 
Genomics literacy in science education and 
Educating for visual literacy in a genomics world: 
fostering imagery of cellular and molecular 
dynamics in science education). 
CluSteR 2
Experts in public interaction 
-  General practitioners urgently need 
postgraduate training on genetics, family 
history, ethical dilemmas and the organisation 
and role of clinical genetic centres (project 
Developing training in genetics/ genomics for 
primary health care workers).
-  Scientists who participate in public debate or 
dialogue events, tend to limit their role to that 
of the neutral and objective expert (project 
Talking genomics: experts and publics at DNA 
public debates and events).
-  The emotions that companies use to persuade 
the public of the benefits of industrial 
biotechnology do not catch on, because the 
general public is not familiar with the idea 
of a bio-based economy (project The value of 
emotions for triggering an articulated public-expert 
interaction for sustainability).
CluSteR 3
Improving dialogue and interaction
-  A Societal Interface Group can provide 
genomics centres with an institutional 
framework for the facilitation of public 
dialogue (project Distributed expertise in plant 
genomics).
-  An understanding of interaction as collective 
learning or dialogue allows ELSA researchers 
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to productively deal with tensions between a 
more analytical or a more applied orientation 
in their projects (project Situated interactions: 
translating ELSA genomics research in practice). 
2.3 Relevance
Quality is about doing things well, relevance 
is about doing the right things. The CSG Next 
programme aims to do the right things for 
their academic peers as well as for a number 
of target groups, and do them well. In light 
of CSG’s mission and profile the distinction 
between relevance and valorisation, made in 
the evaluation framework of NGI, is difficult to 
maintain. CSG considers the wider relevance 
of its programme in light of the different target 
groups that have been identified. The relevance 
of the CSG Next programme for the target 
groups, including the NGI centres, is key to the 
programme’s existence and therefore an important 
constituent for the evaluation of its quality. Here 
we consider the relevance of the CSG programme 
for the field of ELSA genomics research and for 
the NGI Centres. In chapter 5 (Valorisation), we 
address the value of the programme for societal 
target groups. 
Relevance for the ELSA genomics field
Indicators for the relevance of the CSG-
programme for the field of ELSA genomics 
research are (international) collaborations, 
citations, (invited) lectures and participation 
in network activities. We should note here that 
using the term ‘ELSA’ is not without its problems. 
Many researchers would not coin their own 
work as ‘doing ELSA’, although it is obvious that 
they meet most of the characteristics that make 
up CSG’s view on ELSA (object of research, 
interdisciplinarity, interactivity). We can see 
the number of collaborations between CSG 
researchers, but also with researchers within their 
own institutional environment gradually growing. 
Because the CSG programme is relatively young, 
the number of citations from CSG project results 
are still low. The number of (invited) lectures 
is growing exponentially, which is a sign that 
CSG’s researchers are gaining prominence. A 
major contribution has been the education of 
a generation of young researchers equipped to 
conduct and further develop high-quality research 
that is relevant to the development of new 
and emerging (life) science and technology in 
society. Moreover, the programme has performed 
a prominent role in the development of a 
methodological and conceptual framework for 
interactive ELSA life sciences research in the 
Netherlands and beyond, by means of researchers’ 
meetings, workshops, international conferences, 
talks and publications. 
Relevance for NGI and genomics centres
A central feature of CSG’s programme and 
profile is its proximity to the other centres of 
the Netherlands Genomics Initiative. On the 
one hand, the centres and the researchers that 
they accommodate, are one of the target groups 
that have been identified for the CSG Next 
programme. Like the other – societal – target 
groups (stakeholders, policy makers, students and 
citizens or the general public), genomics centers 
and researchers are involved in CSG-projects 
and activities as partners, (prospective) users or 
‘Research into the social 
aspects of life sciences is 
indispensable for a strong life 
sciences sector’ 
Partners in the Polder, 2009 
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beneficiaries. On the other hand, CSG and the 
other centres are part of the same infrastructure, 
being NGI. Thus, CSG’s relevance is partly 
derived form its added value for the Dutch 
genomics infrastructure.
At the request of NGI, CSG has participated in 
strategy development for the Dutch life sciences 
sector as secretary for an independent commission 
of experts (chaired by professor Wiebe Bijker, 
Maastricht University) who wrote a chapter on 
‘social aspects’ in the book ‘Partners in the polder. 
A vision for the life sciences in the Netherlands 
and the role of public private partnerships’. Three 
core messages were formulated:
-  Research into the social aspects of life sciences 
is indispensable for a strong life sciences sector.
 -  Organised interactions – participation, 
engagement, dialogue and education – with 
and between different stakeholders and civil 
society are necessary for a democratic and 
thereby sustainable development of the life 
sciences and technologies.
-  Good governance of social issues surrounding 
life sciences innovation requires the 
facilitation of checks and balances between 
different types of knowledge, discourses and 
views. 
NGI has commissioned, as part of the midterm 
evaluation, a review of the ‘added value’ of the 
CSG programme for the NGI network. At the 
time of writing this report, we do not know the 
results of that review yet. Here we present some 
more general remarks as a context for those 
results. The CSG Next programme has been 
developed and conducted in close collaboration 
with genomics centres. Collaboration has been 
framed as partnership rather than as service-
provision (by CSG to NGI centres). CSG projects 
relate to the work done in genomics centres and 
address topics which are relevant to that work. 
Moreover, CSG projects address societal concerns, 
challenges and opportunities evoked or facilitated 
by activities and results of NGI genomics centres. 
Therefore, the CSG research agenda partly 
follows the development of the genomics field. 
Research quality and credibility, however, 
require academic freedom and autonomy. 
Genomics researchers are highly valuable and 
valued informants, as well as participants in 
supervisory boards for CSG research projects 
and in workshops, debates and other activities. 
However, final responsibility for framing research 
questions and publish results, conclusions and 
recommendations resides with the principal 
investigators and project leaders of CSG projects. 
All CSG projects, including those that aim 
for translation or implementation of genomics 
results, foster an independent, reflective and 
constructively critical academic attitude to ELSA 
genomics research. 
The ideal that underlies the CSG Next 
programme is that academic quality and relevance 
go hand-in-hand in societal/ ELSA research 
with an interactive profile, or even reinforce one 
another. Translating that ideal to actual practices 
of research and interaction with genomics centres 
and researchers, however, is not self-evident and 
often difficult. 
Some CSG projects result in critical conclusions 
about genomics research or in unfavourable 
outcomes. Sometimes, critical and unexpected 
results are welcomed by partners as eye-openers 
and as relevant and well-informed comments on 
their work. In other cases, however, they are not 
appreciated, neglected or discarded as irrelevant. 
Such tensions are often implicit. However, they 
have been mentioned and discussed by CSG 
researchers on various occasions, like CSG 
researchers’ days and performance interviews and 
informal interactions with programme managers 
and principal investigators. 
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2.4 International positioning
CSG has evolved into a research centre of 
international prominence. First of all, CSG’s 
research contributes to important issues on the 
international agenda (ranging from genetic 
screening, biobanking, personalised genomics, 
property rights and sustainability up to science 
communication and science education). This 
is reflected for instance in the high level of 
participation of CSG senior staff and early stage 
researchers in international deliberations and 
scholarly exchange. CSG plays a leading role 
in organising international academic meetings. 
Every two years, CSG organises and hosts an 
international Society & Genomics conference 
in Amsterdam, in collaboration with partners 
from the UK and Canada. The 2008 conference 
‘Genomics & society – setting the agenda,’ 
welcomed over 200 visitors. Plenary lectures 
included a contribution by prof Peter de Knijff 
on forensic genomics and Oron Catts on bio-art. 
‘Ten years after – mapping the societal genomics 
landscape’ was the title of the 2010 conference. 
Keynotes included prof Bartha Knoppers on the 
ethics of genomics databases and prof. Mike Jetten 
on the impact of ecogenomics. Attendance: 150 
visitors.
CSG has been actively involved in the 
programme committees of international 
conferences in meetings in ELSA genomics and 
various sub-field in many countries including 
the UK, Austria, Sweden and Canada. CSG is 
represented in Scientific Advisory Boards and 
Peer Review Committees in the area of ELSA 
Life Sciences in a number of countries e.g. on 
behalf of the ESRC Genomics Network (UK), 
Genome Canada, GEN-AU (Austria), ELSAGEN 
(Germany, Austria, Finland). Together with EGN, 
CSG publishes the academic journal Genomics, 
Society and Policy. CSG plays a leading role in 
an emerging international network that aims to 
evolve into a European platform for ELSA life 
sciences research by means of applications (EU 
Calls), position papers, and academic as well as 
policy conferences. Currently, CSG coordinates 
a promising proposal for launching a series of 
programmatic conferences (ESF Conference 
Series). Since 2008, CSG has been involved in 
Workpackage 4: Ethical, Legal and Societal Issues 
of the 3-year GEN-AU project Genome Austria 
Tissue Bank (GATib). Workpackage leader is prof 
Herbert Gottweis (University of Vienna). CSG 
participants: prof Gerard de Vries, dr Jacqueline 
Broerse, Martin Boeckhout and dr Annemiek 
Nelis. 
At present CSG hosts two NGI Distinguished 
Visiting Professors. Prof. Bartha-Maria Knoppers is 
Director of the Centre of Genomics and Policy at 
McGill University in Canada. She is an expert in 
the field of law, ethics and biobanks. CSG shares 
her Distinguished Visiting Professorship with the 
Centre for Medical Systems Biology (CMSB). 
In 2010, professor Knoppers has acted as a 
plenary speaker at the CMSB and CSG scientific 
conferences. In addition, she participated in 
various research meetings, including a CSG 
master class, and is presently preparing a number 
of collaborative articles with CSG principal 
investigators and researchers.
Prof. Massimiano Bucchi, is a professor in 
sociology of science and science communication 
at the University of Trento, Italy. He is shared 
Distinguished Visiting Professor for CSG and 
the Kluyver Centre for Genomics of Industrial 
Fermentation. Besides working on his next 
book, professor Bucchi will present his work 
and participate in discussions at a number of 
conferences and research meetings organised by 
CSG and the Kluyver Centre.
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academic output 2008 2009 2010 2011 2012 2013 Cumulative nGi targets
1. Articles total 39 86 113 238 250
    a. of which: Articles IF> 5 3 5 1 9
    b. of which: Articles IF > 10 2 1 3
    c.  of which: other academic  
publications 6 7 12 25
2. Invited academic lectures 38 43 38 119
3.  Academic presentations  
(peer reviewed) 27 40 79 146
4. Other academic presentations 16 67 52 135
5. Theses 0 1 1 2 20
Personnel 2008 2009 2010 2011 2012 2013
technical staff
PhD students 11 25 27
Postdocs 6 16 16
Junior researchers 2
Associate/ Assistant Professors 2,0 2,6 2,6
Full professors 1,4 1,4 1,4
Management 2,4 2,4 2,0
Vacancies 8 4 5
Partners
Number of academic partners 13 15 16
Number of industrial partners - -
Societal output 2008 2009 2010 2011 2012 2013 Cumulative nGi targets
6. Societal publications 18 28 72 118 50
7. Societal presentations 30 26 36 92
8. Public debates 15 10 3 28 55
9.  Educational activities or events (not 
being: DNA labs or contributions to 
www.watisdna.nl)
1 3 1
10.  New (non commercial) clinical  
applications (e.g. protocols) 1
11.  New products available to the public 
(e.g. non commercial tools) 1
12. Advice / reports (e.g. policy reports) 1 2 1
13. Visitors to public website 242.049 240.565 91.167
240.000 
yearly
14. Visitors to DNA-labs on the road 14.405 17.400 17.762
16.000 
yearly
3 Chapter 3Productivity
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Clarification
-  Category 1 (238 in total) are academic peer-reviewed articles (213 in total), as well as articles for professional journals, 
book chapters and other articles for an academic audience in non-peer-reviewed journals (25 in total). Category 1 
includes the output from CSG researchers and project leaders as well as the output from principal investigators and 
CSG directors.
-  Category 2 are invited academic lectures, which are indicative for the (national and international) visibility and 
reputation of CSG research.
-  Category 3 are abstracts and papers presented at academic meetings and conferences, which have been selected by 
peer review.
-  Category 4 are other presentations for an academic audience that have not been selected by peer review.
Academic partners in 2010
Radboud Universiteit Nijmegen
Universitair Medisch Centrum St. Radboud
Universiteit van Amsterdam
Academisch Medisch Centrum Amsterdam
Vrije Universiteit Amsterdam
VU Medisch Centrum
Erasmus Medisch Centrum
Universiteit Leiden
Leids Universitair Medisch Centrum
Universiteit Utrecht
Universitair Medisch Centrum Utrecht
Technische Universiteit Delft
Universiteit Maastricht
Universiteit Twente
Wageningen University & Research Centre
TNO Quality of Life
Details on the academic and societal output can be found in Chapter 4 and in Annex 4. 
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Education and communication activities are part 
of programme 3. This structure facilitates close 
connections between the research projects in 
that programme and a number of communication 
and education projects. Yet, the education and 
communication activities are also distinguished as 
a separate part of the CSG Next programme. This 
chapter presents its position in the programme, 
the leading vision for communication and 
education activities and projects, and the results 
so far. 
4.1  Introduction
In 2002, there was little public knowledge about 
genomics. A comparison between national public 
surveys on genomics in 2002 and commissioned 
by CSG in 2005 indicated little difference. 
Typical genomics applications such as ‘mapping 
DNA to prevent diseases’ and ’use of gene 
technology against breast cancer’ were evaluated 
as positive4. The term ‘genomics’ as such could 
not be used in public questionnaires, as the vast 
majority did not know its meaning. At the start of 
the century, materials and methods used in DNA 
education at secondary schools dated back to the 
monogenetic era. 
For CSG and other NGI genomics centres, the 
combination of large public investments in this 
technology on the one hand, and the absence of 
genomics in the public domain and in education 
on the other hand was the main reason to develop 
a communication and education programme, in 
combination with research that aims at studying 
and improving genomics communication and 
education.
From CSG’s start in September 2004, the 
centre has developed and hosted many public 
communication and education activities. Most 
of these were set up in close cooperation with 
other genomics centres, notably the five centres 
that started in 2003/20045. Later, other genomics 
centres joined this group6 as well as partners 
including science centres, science museums, 
public websites and debate centres. CSG has been 
the coordinator of genomics communication for 
NGI. In addition, since 2008, CSG coordinates 
NGI’s most prominent education activity: the 
DNA-labs on the Road. In 2008, many of the 
genomics centres participated in the national 
October Month of Knowledge.
4.2  Vision on public 
communication & education
CSG’s vision on public communication and 
education is laid down in the business plan for 
CSG Next, which stated as its ambition “that 
genomics governance is well organised” and 
formulated as requirements for this objective:
a.  That citizens, genomics researchers, researchers in 
the field of the Ethical, Legal and Social Aspects 
of genomics (ELSA), NGO’s and industry 
have more expertise about the societal aspects of 
genomics.
b.  That dialogue with the public on potentially 
controversial applications of genomics takes place 
at an early stage and in an open-minded and well-
informed way.
In other words, CSG aims to increase knowledge 
and awareness of genomics in a societal context 
4.  Renske Pin & Jan Gutteling, Publieksonderzoek Genomics 2005, December 2005
5.  Centre for Medical Systems Biology (CMSB), Cancer Genomics Centre (CGC), Centre for BioSystems Genomics (CBSG), Kluyver Centre 
for Genomics of Industrial Fermentation (KC) and Netherlands Bioinformatics Centre (NBIC)
6.  Netherlands Proteomics Centre (NPC), Ecogenomics Consortium (EC) and Forensic Genomics Centre Netherlands (FGCN)
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with scientists, publics and stakeholders. CSG 
does not aim to increase public support of 
genomics research or applications. 
CSG realised from the start that its role as 
coordinator and initiator of communication 
and education activities for NGI could produce 
tensions. Some NGI centres and stakeholders 
regard CSG’s communicaton and education 
activities as a means to increase citizens’ support 
for genomics, while others saw its main value in 
the empowerment of (future) citizens, irrespective 
of their resulting attitude towards genomics.
CSG’s communication and education activities 
are connected to several research projects in the 
CSG Next programme, especially in programme 
3. These research projects study education and 
communication activities of CSG and provide 
input for the improvement of these activities.
4.3  Education – approach & results
aPPRoaCH
Most genomics education activities of NGI’s 
genomics centres focus on upper secondary school 
(bovenbouw havo/ vwo). The reason for this 
selection is that for understanding the concepts 
of genomics or life sciences, basic knowledge 
of DNA and cells is required. In addition, 
these students may consider to enrol for higher 
education in the life sciences.
The education activities provide direct access to 
classrooms and the chance to introduce genomics 
in the curriculum. CSG’s main interest lies in 
empowering students, in their capacity as future 
citizens, to assess relevant issues evoked by 
genomics in society and vice versa. 
The education strategy of the participating 
genomics centres consists of the following 
activities:
a.  DNA-labs on the Road: genomics practicals 
in biology and chemistry classes in upper 
secondary schools, facilitated by universities;
b.  AllesoverDNA.nl: popular-scientific website on 
genomics;
c.  Imagine …: school competition in which 
secondary school students cooperate with life 
scientists in mutual projects in developing 
countries.
The genomics centres have been very active in 
education; many activities have been carried 
out jointly. In particular those involved in the 
DNA-labs on the Road and AllesoverDNA.nl 
have formed a vivid community in which good 
practices are shared, and with mutual support. 
The following activities are part of a joint 
initiative of the genomics centres and universities 
that participate in these activities:
- Communication with teachers,
- Public relations,
- Over-all upgrading of the labs,
- Embedding in secondary education,
- Continuation of the labs after 2012. 
At the same time, all participants have their own 
responsibility concerning quality control and local 
embedding of the activity. CSG’s role is that of 
coordinator and initiator of shared activities.
In 2009, CSG co-initiated a local Science Hub at 
the Radboud University Nijmegen, an initiative 
which links primary education to the university.
ReSultS PeR aCtivity
a. Dna-labs on the Road
Background & approach
Based on the ‘mobile practicals’, developed 
by Wageningen-UR, five of NGI’s genomics 
centres, each in combination with a university 
or university medical centre developed a DNA-
lab on the Road. From January 2006, university 
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students have travelled in pairs to secondary 
schools throughout the country to teach the lab 
during a 2-hour course. The life sciences practicals 
are accompanied by teaching modules for 
introductory and concluding lessons. The latter 
offer the students an introduction in the context 
and the techniques as well as an elaboration of 
related societal issues and advanced research 
topics. In 2010, a forensic DNA-lab was added 
to the existing five. The DNA-labs are a vehicle 
for introducing concepts about DNA and  life 
sciences in a societal context. Societal issues 
in the concluding lessons include: assessing the 
risks of genetic testing, ethical aspects of genetic 
testing, in professional sports, pros and cons of cis-
genesis, pros and cons of lab animals.
Initiatives with similar goals have started 
elsewhere in Europe. For instance, in France 
the Strasbourg University PhD School Life and 
Health Sciences in 2008 launched an initiative 
called OpenLab. Since 2003, the European 
Molecular Biology Laboratory in Heidelberg offers 
in-house training for secondary school teachers 
called LearningLabs and TeachingBase. 
Since 2008, CSG serves as coordinator and – via 
NGI – as funder of the DNA-labs on the Road. 
The DNA-labs benefit from a central coordinating 
organisation, through mutual learning and the 
efficient use of digital communication. CSG’s 
strategy has focused at the improvement of 
the quality of the labs, as well as guaranteeing 
continuity after 20127. Expertise is provided by 
four research projects on genomics education8. 
Results
The combination of joint improvement and 
research has resulted in a coherent product. At 
present, the labs present themselves as one brand. 
The DNA-labs have been highly successful; they 
provide a very welcome addition to the regular 
curriculum, as indicated by many teachers after 
a lab visit. Within five years (January 2006 – 
December 2010), the DNA-labs have visited over 
3.300 classes and almost 80.000 secondary school 
students participated. Approximately two-thirds 
of Dutch secondary schools that offer havo/ vwo 
have participated. These numbers are unparalleled 
in comparison with similar initiatives in Europe.
Dna-lab initiator / coordinator students class visits
Read the language of the tumor CGC/ UMCU 6.133 244
Prenatal research in plants CBSG/ WUR 4.936 204
Racing on toilet paper KC/ TUD 2.636 107
Bioinformatics: a bit of life NBIC/ RU 1.507 61
Healthy or ill: Just a single wrong fold CMSB/ UL 2.350 128
Forensic DNA Research: puzzling with peaks* FGCN/ its labs/ UvA 200 9
total 17.762 753
Numbers of secondary school students and class visits in 2010
*Started January 2010
8.   De Praktijk, Vast en beter - Plan van Aanpak Reizende DNA-labs 2008 – 2012, januari 2009.
9.   (1) DNA-labs for citizenship; (2) Towards a strategy for embedding genomics literacy in science education: In search of common 
concepts and issues; (3) Educating for visual literacy in a genomics world: fostering imagery of cellular and molecular dynamics in 
science education; (4) Genomics education in prevocational schools.
10.   M. Van Mil et al (2010) Genomics Education in Practice: Evaluation of a Mobile Lab Design, BAMBED, Vol. 38, No. 4, pp. 224–229. 
11.   M. Knippels et al, De Reizende DNA labs - Een evaluatie van vijf innovatieve onderwijsmodules, oktober 2006.
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primary school children4
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An estimated 35% of all Dutch secondary 
school students in biology classes participate at 
some time during their education9. Per school 
student, the costs amount to e 40/ 50,- (including 
lab development, lab coordination, BSc/ 
MSc education, travel, equipment and public 
relations).
In spite of the successes, the DNA-labs have been 
under continuous scrutiny; improvements are 
made regularly. A 2006 evaluation of the DNA-
labs concluded that the majority of participating 
students and teachers were positive and that 
between 9 and 16% of the students consider to 
study (life) science as a result of the lab visit10. 
The evaluation also showed that many high 
school teachers did not teach the introductory 
and concluding courses. Moreover, the knowledge 
gain in four labs, as experienced by students, was 
too small and opinion forming too limited. Recent 
improvements have addressed these aspects. 
-  The DNA-labs have been redesigned and now 
contain more teacher support, and modules 
can also be taught independently of the lab.
-  By offering each lab at two levels of expertise 
(basic and expert), the practicals are more 
tailor-made.
-  Special modules provide guidance for lessons 
on opinion forming. 
Teach the teacher
Secondary school teachers and their technical 
assistants (‘TOAs’) are invited for refreshment 
courses about the DNA-labs. On March 12th, 
CSG organised the first national DNA-lab day, 
in which 170 secondary school teachers and 
technical assistants (TOAs) participated. They 
were offered plenary lectures by Peter de Knijff 
(Forensic Genomics Consortium Netherlands) 
and Jan Hoeijmakers (Erasmus MC Rotterdam) 
and a wide variety of practical and educational 
workshops. In addition, most DNA-labs offer 
teacher training courses or offer workshops at 
teachers’ conferences several times per year. 
BSc and MSc courses
The labs provide bachelor and master students 
with the possibility to teach at secondary schools. 
The Utrecht and Wageningen lab training 
is part of successful bachelor education & 
communication courses for which students obtain 
ECTS (study credits). In Utrecht a 2010 BSc lab-
course welcomed the 100th student.
Spin-offs
The labs have had numerous spin-offs:
-  All the labs offer input for a renewed science 
curriculum in which genomics education is 
embedded;
-  Module at Utrecht junior college (last year 
of secondary school), based on the Utrecht 
DNA-lab;
-  Module at Rotterdam Junior Science 
Programme (last two years of secondary 
school);
-  Modules on bioinformatics and cancer 
for Advanced Science, Mathematics and 
Technology-lessons (NLT-vak);
-  The Delft DNA-lab is integrated in Science 
Centre Delft;
-  The forensic lab is used for a regular 
refreshment course for technical detectives 
and other professionals in the criminal chain;
-  The bioinformatics lab offers support 
and various lab modules to be taught 
independently by teachers.
b. Website allesoverDna
Background & approach
The website www.allesoverDNA.nl (‘all about 
DNA’) provides information on genomics/ life 
sciences for a broad audience. The website aims 
at opinion forming, not at influencing public 
opinion in any given direction. 
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When AllesoverDNA went online in 2005, it 
was positioned as a public website, containing 
items such as background articles on genomics 
applications and with links to genomics centres 
and other scientific institutes. Analysis of 
responses and actual use showed that the site was 
used mostly by secondary school students. Based 
on the results from evaluations in which teachers 
and school students participated, the website was 
redesigned for use in secondary education. At 
present the website contains more information on 
genomics basics as well as teaching modules, news 
and recent dossiers. The site has also become the 
central hub for the DNA-labs on the Road.
Results
The website is visited monthly by 20.000 – 30.000 
visitors. Last year has showed a decline in the 
number of visits, probably due to the use of a 
new Content Management System. The number 
of visits corresponds with the school year, with 
lowest numbers in summer and December and 
maximum numbers in between.
c. imagine …
Background & approach
Imagine… is an annual school competition 
inviting life scientists to submit proposals for 
the application of a specific useful and affordable 
technology in a developing country. Secondary 
school students (in groups of 2-5, aged 15-18) set 
up a business plan for the proposal of their choice. 
For students this activity is their masterpiece 
(‘profielwerkstuk’) performed in the highest class 
(of havo/ vwo). 
Imagine… aims to: 
-  Increase interest in life science and technology 
among schools;
-  Promote technical education among schools 
by getting to know practical applications of 
science;
-  Challenge scientists to device useful 
applications of their research to aid the 
developing countries;
-  Expose the research field to a broader 
audience.
Imagine.. is an independent initiative, supported 
by the Kluyver Centre and CSG. These centres 
share a research project aimed at studying and 
improving Imagine. 
Results 
During Imagine’s 7 years of existence 600 students 
at 60 schools were made enthusiastic about 
biotechnology and the potential for developing 
countries. As part of the competition, students get 
acquainted with science practice.
The competition has evoked a total of 50 project 
proposals and 176 masterpieces. The 45 scientists 
that took part in the competition, were stimulated 
to develop biotech solutions for developing 
countries. In particular the finals have led to a lot 
of media attention.
The projects that won:
-  Tested the local production of biodiesel in 
Mozambique (2004)
-  Taught people in Kenya how to distil oil from 
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avocado kernels (2005)
-  Saved a colour producing plantation in 
Surinam (2006)
-  Initiated the production of oyster mushrooms 
in Ghana (2007)
-  Introduced a course for the production of 
biogas in Tanzania (2008)
-  Will extract pectin from orange peels in 
Colombia (2009)
-  Will introduce transportable equipment for 
producing biogas for cooking in Guatemala 
(2010)
local initiative: 
nijmegen Science Hub
Since 2009, CSG hosts the Nijmegen Science 
Hub (Wetenschapsknooppunt), a local initiative 
that brings together teachers and pupils at primary 
schools, researchers of the Radboud University 
and teachers/ students of the HAN University 
of Applied Sciences. The goal is to translate 
academic insights into tailor-made lessons for 
primary education. The Nijmegen Science Hub 
has set an example for similar hubs throughout 
the Netherlands.
leSSonS leaRneD 
Genomics education has had special support 
since 2003 (Imagine…) resp. 2005 (DNA-labs). 
As financial support is likely to be discontinued 
from 2013 onwards, CSG has opted to invest in 
embedding genomics education in the secondary 
schools’ science curriculum itself. Ideally, 
teachers are empowered so that they can teach 
life sciences and DNA practicals themselves. 
However, genomics science is always miles ahead 
of current school curricula and there are good 
reasons to maintain lasting relationships between 
universities and schools. 
CSG and the other genomics centres and 
universities actively seek ways to ensure 
continuity, by:
-  The embedding of labs, such as in science 
centres;
-  Offering paid school visits;
-  Exploring possibilities for additional funding;
-  The redesigning of the website 
AllesoverDNA.nl into a central hub for 
science education, to increase usability by 
teachers and school students.
4.4  Public communication –
approach & results 
aPPRoaCH
The aim of CSG’s public communication 
programme is to equip citizens, genomics 
researchers, ELSA researchers, NGOs and 
industry for decision-making and opinion-
formation on issues at the interface of genomics 
and society. CSG’s communication programme 
Student visits mushroom project in Ghana
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is supported by various research projects that 
study public interaction. Communication is 
also an integral part of each of CSG’s research 
projects; researchers invest in relationships with 
stakeholders and use their input at an early stage 
in their projects. 
ReSultS 
Public communication activities are partly 
organised on behalf of CSG, and partly on behalf 
of other genomics centres. CSG also contributes 
to activities initiated by other centres. 
Selected examples
Debate series ‘genes & behaviour, 
2008
The series the ‘Pre-programmed man’ consisted 
of three debates organised in LUX-Nijmegen, 
themed: ADHD, anti-social behaviour and 
autism. The moderator, also one of CSG’s 
researchers, used the debates to study the 
influence of the interaction with the audience on 
experts. The moderator studied the interaction 
between the audience and the experts, and 
actively intervened with the aim to get the 
experts out of their comfort zones – which proved 
to be a difficult task. 
Public events: october Month of 
Knowledge 2008
Each year, in fall, The National Centre for 
Science and Technology (NCWT) organises 
the October Month of Knowledge. During this 
month 250.000 people visit one of many science-
related activities throughout the country. The 
2008 theme, ‘Crack the code’, was related to life 
sciences. CSG closely cooperated with NCWT 
and coordinated the public activities on life 
sciences that were carried out by NGI’s genomics 
centres. Activities included local events in nine 
cities, a national event in Leiden and a popular 
book on DNA (‘DNA etcetera’).
Public events: ten years after
Ten years after the publication of the first draft 
of the human genome, CSG organised a public 
debate in De Rode Hoed in Amsterdam ‘Lang 
leve DNA’ (may, 26th 2010). Chaired by science 
journalist Simon Rozendaal, human geneticist 
Gert Jan van Ommen and CSG’s Hub Zwart 
commented on the impact of the human genome 
sequence and shared their future expectations. 
In addition, (parents of) patients with genetic 
diseases shared their experiences.
Designers & artists 4 Genomics 
award
The Designers & Artists 4 Genomics Award 
(DA4GA) is the first Dutch competition for the 
combination of art, design and life sciences – 
an initiative of De Waag Society, Netherlands 
Genomics Initiative and CSG. The aim of 
DA4GA is to foster Bio Art and to visualise 
the diversity of genomics. Bio Art is a form of 
art which uses living tissues and organisms as a 
medium.
On Wednesday 8 December 2010, Robbert 
Dijkgraaf, president of the Royal Netherlands 
Academy of Arts and Sciences (KNAW), awarded 
the three best projects – by Maurizio Montalti, 
Jalila Essaidi and Matthijs Munnik - with a 
‘DA4GA’ in science museum Naturalis in Leiden. 
The jury felt that the three winning designs are 
sensational both artistically as well as scientifically 
and furthermore of great social relevance, because 
of the linking of scientists to designers. The 
winners received e25.000, to be spent on the 
realisation of their proposal that will be on show 
from mid-June until the end of December 2011 in 
Naturalis.
Popular publications
Besides a report series for publications about the 
final results of CSG projects, CSG issues popular 
publications to share the results of its programme 
(including research as well as communication) 
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Debate on autism in series on 
genomics & behaviour
Nijmegen, 16 December 2008
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to an interested audience. Examples from the 
CSG Next programme are ‘DNA etcetera. 
AllesoverDNA’, for secondary school students and 
interested others, based on the popular website 
AllesoverDNA.nl and ‘Om gek van te worden. Het 
complexe verband tussen psyche en genen’ (‘It drives 
you mad: the complex relation between psyche 
and genes’), based on a CSG I research project on 
psychiatric genomics. In 2008 De Jonge Akademie 
(young scientists of the Academy (KNAW) and 
CSG published a popular book ‘The modifiable 
human’ (De Maakbare Mens). The book provides 
an outlook on the (future) possibilities for the 
enhancement of human beings and related ethical 
issues. 
leSSonS leaRneD
CSG has increasingly been uncomfortable with 
the notion of ‘the general public’. Citizens present 
a very diverse cluster of groups, each with their 
own background knowledge and interests. Public 
communication activities have been targeted at 
specific publics, including patient groups, NGO’s 
and genomics professionals, often in connection 
to CSG research projects. Before organising 
a debate or event, CSG contacts potentially 
interested or affected parties and develops a 
tailor-made approach, in close cooperation with 
these parties or individuals. CSG’s increasing 
focus on targeted activities for particular public 
groups or stakeholders – often in connection 
with one or more CSG research projects - has 
resulted in a reduced number of more general 
activities like festivals or popular publications. 
The ‘general public’, however, has been identified 
as a target group in the business plan for CSG 
Next, indicating CSG’s role in coordinating 
communication activities for NGI and its centres. 
The combination of research and communication 
presents a valuable constituent of CSG’s distinct 
profile. It contributes to the visibility, relevance 
and societal value of the CSG Next programme. 
However, the increasing focus in communication 
activities on target groups rather than on 
the general public can be at odds with more 
general communication activities expected or 
commissioned by NGI and genomics centres. 
oveRvieW of aCtivitieS
CSG Debates 2008
-  Actualiteitsdebat: Embryoselectie – Lux Nijmegen & 
CSG, 19 juni 2008
-  De voorgeprogammeerde mens, deel I: ADHD – Lux 
Nijmegen en CSG, 30 juni 2008
-  De voorgeprogrammeerde mens, deel II: Criminaliteit 
– Lux Nijmegen en CSG, 17 november 2008
-  De voorgeprogrammeerde mens, deel III: Autisme – 
Lux Nijmegen en CSG, 16 december 2008
-  Wetenschap voor de toekomst! Synthetische 
biologie, de voortdenderende wetenschap, met 
o.a. Colja Laane, directeur Genomics Initiative, 
Bert Poolman, hoogleraar Biochemie en directeur 
‘Centre for Synthetic Biology’, Dr, Henk van den Belt, 
wetenschapsfilosoof Universiteit Wageningen en 
Steven Flipse en Bas van den Berg, studenten van TU 
Delft - TUMULT & CSG - 1 december 2008, Utrecht
-  Leeftijd: 250! De wensdroom van het eeuwige 
leven, met o.a. Prof. Dr. Jan Hoeijmakers, hoogleraar 
moleculaire genetica en Prof. Dr. Gerald de Haan, 
hoogleraar celbiologie aan Rijksuniversiteit Groningen, 
Dr. Fleur Thomèse van Vrije Universiteit van 
Amsterdam – TUMULT & CSG – 29 oktober 2008, 
Utrecht 
-  Kenniscafé: CSI & Jurassic Park, Pieter van der 
Wielen interviewt Peter de Knijff, populatiegeneticus 
Universiteit Leiden, met columns van Bas Haring en 
Marcel Hulspas – TUMULT, Noorderlicht, Universiteit 
Utrecht en CSG – 10 september 2008
-  Filmdebat over The Dodo Game met Fons Werry 
(Wageningen Universiteit) en Hub Zwart (CSG) - 
Biotopia? - 18 oktober 2008 - LUX-Nijmegen
-  Lagerhuisdebat over biobrandstoffen, gentech en 
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voedselcrisis, met Liesbeth van Tongeren (Greenpeace 
NL) en René Custers (Vlaams Instituut voor 
Biotechnologie) – 18 oktober 2008 – Lux-Nijmegen
-  Marathoninterview – leven in het lab? Met 
onderzoekers van Radboud Universiteit Nijmegen 
en het UMC St. Radboud – 18 oktober 2008 – Lux-
Nijmegen
-  Drie toepassingen van genomics: toxico-, farmaco- 
en carcinogenomics – 16 oktober 2008 – Aula 
Tongersestraat 53 te Maastricht
-  De genetische code is gekraakt: gaat de doos van 
Pandora open? Met prof. dr. J. Geraedts, hoogleraar 
genetica, UM en prof. dr. G. de Wert, hoogleraar 
medische ethiek, UM – 2 oktober 2008 – Aula 
Tongersestraat 53 te Maastricht
-  Online debat over autisme op OudersOnline, 30 mei 
2008 http://www.ouders.nl/mgez2008-autisme.htm
-  Studium Generale – Klare taal voor het genomics 
debat – de universiteit als bakermat van het 
publieksdebat, sprekers: Frans van Dam (Centre 
for Society and Genomics) en Harry Kunneman 
(Universiteit voor Humanistiek), 9 oktober 
2008, Universiteit Utrecht http://www.sg.uu.nl/
prog/2008b/klare_taal.html
CSG Debates 2009
-  Gaan we straks eten wat ons DNA ons voorschrijft? 
Science Café over voeding en onze genen 27 mei 
2009, Enschede
-  Grieppandemie: complot, paniekzaaierij, sisser of 
bedreiging? 17 september 2009, Lux, Nijmegen met 
o.a. Ab Osterhaus en Roel Coutinho
-  Bepaalt onze genetische herkomst onze identiteit? 18 
oktober 2009, Museum Boerhaave, Leiden met Peter 
de Knijff en Amade M’charek
-  Genetische tests via internet: vrijgeven of reguleren? 
18 oktober 2009, Museum Boerhaave, Leiden met 
Martina Cornel en Annemiek Nelis
-  Hoe maakbaar is de mens? De menselijke identiteit 
van gister, vandaag en morgen, 11 november 2009, 
Museum Boerhaave, Leiden met Christoph Lüthy, Hub 
Zwart en Bert-Jaap Koops 
-  De grieppandemie – paniekzaaierij, sisser of reële 
dreiging? 17 november 2009 Met Ab Osterhaus en 
Roel Coutinho 
-  Salonlezing: Biografie van de vrouw ‘zonder 
geheimen’ 18 november 2009, Museum Boerhaave, 
Leiden met o.a. Marjolein Kriek
-  De Maakbare mens – een interactieve boekpresentatie 
20 november 2009, LUX, Nijmegen met a.a. Sunny 
Bergman, Jeroen Geurts, Bert-Jaap Koops, Joris 
Veltman, Peter-Paul Verbeek, Annemiek Nelis
online debates
-  Een genetische test voor Coeliakie? Praat mee! – 
online dialoog over glutenintolerantie en genetisch 
testen, www.glutenvrij.nl en www.flaironline.nl mei 
2009 
-  DNA doet er toe, maar hoe? Ga hier in gesprek met 
onderzoekers, psychiaters en andere geïnteresseerden, 
online dialoog over schizofrenie en genetica op 
website van GROUP, Anoiksis en Ypsilon. http://www.
ypsilon.org/group_forum november 2009
CSG Debates 2010
-  First national DNA-lab day, Utrecht, 12 March 2010
-  Public debate in De Rode Hoed in Amsterdam ‘Lange 
leve DNA’ (may, 26th 2010), with Hub Zwart and Gert 
Jan van Ommen
-  Stakeholder Dialogue, 12 October 2010. Stakeholders, 
policy-makers and experts were asked to define the 
most urgent societal issues in life sciences.
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5.1  Vision on valorisation
Valorisation is a Gallicism which has been 
introduced in the Netherlands to describe the 
process of adding (economic) value to scientific 
research. Since the start of the Netherlands 
Genomics Initiative, valorisation has been on top 
of the agenda. Genomics Centres receiving grants 
from NGI were stimulated and supported to create 
economic value out of their research by creating 
patent portfolios, licensing out patents, create 
spin off/ spin out companies, and attract matching 
grants from industry. This notion of economic 
valorisation is now common. It has little meaning 
for the CSG Next programme of societal research 
and interaction, with the improvement of the 
conditions for embedding genomics in society as 
one of its objectives. The value of the programme 
is to be considered in terms of the utility value of 
research and communication/ educations projects 
and results rather than of their exchange value. 
The societal value of the CSG Next programme 
comes true in the extent to which its results can 
be used by genomics researchers and societal 
target groups.
As stated in chapter 2, the distinction between 
relevance and valorisation, made in the 
evaluation framework of NGI, is difficult to 
maintain in light of CSG’s profile. The value 
of the CSG Next programmes is equal to its 
relevance for the different target groups that have 
been identified in the business plan. In chapter 
2 the value of the CSG programme for the NGI 
centres was considered. Here, the value of the 
programme for societal target groups is addressed. 
5.2  Valorisation Strategy
CSG’s valorisation strategy follows from the 
construction of the CSG Next programme (see 
chapter A.2). Four main objectives derived from 
CSG’s mission have been formulated:
-  Add to the academic body of knowledge about 
society-genomics relations
-  Strengthen the governance of genomics
-  Improve quality of public debate on genomics
-  Educate researchers, professionals and citizens 
to assess genomics at its value for society
A number of related activities (research, network 
activities, dialogue, communication, education) 
are developed to achieve these objectives in 
cooperation with, or directed at target groups. 
Ideally, research projects are designed and 
executed in an interactive manner with potential 
users, who are actively involved in formulating 
the project objectives and are involved in the 
execution of the project plan. Interaction and 
proximity shape the conditions for research 
projects to have maximum relevance for the 
stakeholders involved. To further enhance the 
utility and usability of CSG activities tangible 
and/ or quantifiable outputs were defined, that 
can be used as tools as well as indicators for 
valorisation, including
-  Publications in specialist journals
-  Public performances
-  Networking activities 
-  Consultancy
-  Use of products/ protocols
-  Popular science publications
-  Organising a public event
-  Organising a workshop for specialists
Valorisation of societal research requires a 
custom-made approach. There is no one-size-fits-
all - a sort of valorisation manual - approach to 
the valorisation of CSG’s projects. Valorisation 
goals and activities depend on the research 
subject, project goals, the target audience (or 
stakeholders), etc. There are, however, some rules 
of thumb to increase the chances of valorising 
results of research projects. 
Chapter 5
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1.   In CSG projects, stakeholders are often not 
just objects of research, but also suppliers of 
the relevant knowledge, and the eventual 
beneficiaries of the results. This implies 
involving stakeholders in formulating research 
objectives and research questions. This 
type of early involvement has been proven 
to contribute substantially to successful 
valorisation, i.e. the projects providing 
relevant research for stakeholders. 
2.   Early involvement is often not enough. Extra 
effort in translating research results with an 
eye on specific stakeholders is necessary, be it a 
publication for a target audience, a workshop, 
a training or master class, etc. 
3.   Research results may have significance for 
a wider audience. They may for example 
be relevant for an ongoing public debate. 
Therefore it might be worthwhile to generate 
media attention. ‘The general public’ however 
proves to be a problematic category. A public 
is defined by the issue at stake, and issues 
seldom become ‘general’. 
4.   Some tentative results of research projects 
may need further development, comparable to 
proof-of-principle studies. 
5.   Always expect the unexpected. Research 
projects may deliver results that were not 
included in the stated goals; also new targets 
groups may emerge during a project, e.g. 
an issue may arise that requires political 
attention. 
6.   In the end, it may take a long time for 
valorised research results to really have an 
impact. 
The hypothesis underlying the internal CSG 
research policy on ‘societal interaction’ (see 
chapter 1) i.e. that CSG research requires the 
integration of interaction with one or more 
target groups into the research process in order 
to have societal value, has been confirmed by 
the experiences in CSG I and CSG Next so far. 
For areas where interactions with target groups 
have been frequent and intense, like secondary 
education, the value of the CSG programmes has 
been considerably higher than for fields where 
target groups have not substantially been involved 
in research projects, like policy and politics.
Notably lagging behind is the impact for two 
targeted groups: the general public, and policy. 
As explained in chapter 4, the general public as a 
target group has largely been abandoned, since a 
key characteristic of the general public is that it 
cannot be targeted as a group nor be a meaningful 
partner for reciprocal interaction. Although 
there are some notable exceptions (in particular 
in programme 1), links with policy-makers and 
politicians had not firmly been established at 
the start of the programme and have remained 
weak. That is why it is difficult to pinpoint the 
value of CSG-research for policy so far. However, 
societal relevance should not be equated to policy 
relevance or (utility) value for policy-makers and 
politicians. Societal relevance also concerns the 
utility for (future) citizens, consumers, patients, 
professionals and entrepreneurs. 
successful valorisation 
requires early stakeholder 
involvement, translation of 
research results, seizing of 
unexpected opportunities 
and patience
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It often takes some time for research to have an 
impact. Most CSG Next projects have started 
less than two years ago. Moreover, impact and 
outcome are notoriously difficult to measure 
or to attribute to particular events or actors. 
Therefore, mainly the societal output of our 
projects is presented in this chapter. Impact is 
only reported if it can be actually demonstrated 
or plausibly assumed. It must also be noted that it 
cannot be stipulated beforehand which outcomes 
would classify as useful. It is a core characteristic 
of research: whether knowledge will actually 
be (considered) useful by others, cannot be 
guaranteed.
In the budgets of all CSG projects reservations 
are made for interactions (workshops, stakeholder 
meetings, etc). To further support the actual use of 
CSG project results a Valorisation Fund of 
e 500.000 was created. The first project that has 
been funded from this source is a feasibility study 
for the commercial exploitation of CSG methods 
and results, resulting from a CSG I research 
project and a project in CSG Next programme 3 
(see below). 
5.3  Valorisation Results
Chapter 3 provides a quantitative account of 
the output CSG project have delivered to date. 
In this chapter a qualitative overview of CSG’s 
valorisation efforts and results is presented. 
Valorisation takes place on the level of individual 
projects as well as on the level of thematic clusters 
in or across programmes. Valorisation activities in 
connection to projects include workshops, expert 
meetings, CSG reports, policy recommendations, 
educational tools, professional guidelines and 
public debates. CSG has also co-organised an 
international Summer Institute on genetics, 
ethics and clinical translation, together with the 
ENGAGE Consortium (European Network for 
Genetic and Genomic Epidemiology) and P3G 
(Publication Population Project in Genomics). 
Now that the programme is halfway, possibilities 
occur for valorisation on higher aggregation 
levels. Notably, a number of activities are being 
developed to present preliminary results from 
CSG Next projects to politicians and policy-
makers on a national level (e.g. on medical-
ethical issues in relation to new development in 
health genomics) and on an international level 
(e.g. in Brussels on international governance 
issues in IPR and the subject of valorisation in the 
food and agricultural domain).
Typical valorisation highlights on the programme 
level include:
objective: add to the academic body 
of knowledge about society-genomics 
relations
Stakeholder dialogue ‘Life Sciences in 
progress’
On October 12 2010, CSG organised the 
stakeholder dialogue Life Sciences in Progress. 
The stakeholder dialogue marked an important 
trajectory of societal valorisation. The event 
resulted from an intensive trajectory of 
stakeholder consultations, interviews and 
discussions about a societal agenda in light of 
current and expected developments in the diverse 
life science fields. The stakeholder dialogue has 
increased the visibility of CSG for stakeholders 
and exemplified its interactive approach to the 
field. Four projects are presently being developed 
based on the ideas generated by participants in 
the dialogue. 
objective: strengthen the governance of 
genomics
Research report for the Trend Analysis 
Biotechnology 2009
In 2009, CSG director Annemiek Nelis and 
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junior researcher Yrrah Stol published the CSG-
report ‘The societal relevance of biotechnological 
trends’. The report was commissioned by the 
producers (Dutch Health Council, Commission 
for Genetic Modification (COGEM) and the 
Commission for Biotechnology in Animals) of 
the so-called Trend Analysis Biotechnology, 
which is published every two years. The results 
of the CSG-report, which took societal issues 
as the starting point for the analysis of relevant 
biotechnological trends, were incorporated in the 
Trend Analysis. The report was also presented 
to the Dutch government as a supplement to 
the Trend Analysis, and will be discussed in 
Parliament in 2011.
objective: improve quality of public 
debate on genomics
‘The modifiable human’
In 2008 De Jonge Akademie (young scientists 
of the Academy (KNAW) and CSG published 
a book ‘The modifiable human’ (De Maakbare 
Mens). The book provides an outlook on the 
(future) possibilities for the enhancement of 
human beings and related ethical issues. It 
contains explorations of possible futures building 
on contemporary research. It is a model for 
conveying a message without reducing research 
results to simple statements and dichotomies.
objective: educate researchers, 
professionals and citizens to assess 
genomics at its value for society
LEV – corporate magazine of the Centre for 
Society and Genomics
With the corporate magazine LEV (in Dutch) 
CSG informs colleagues and stakeholders about 
CSG activities and events and/ or opinions from 
stakeholders relevant to CSG’s mission. LEV 
appears twice a year. The aim of this magazine 
is to inform its readers about the topics that 
concern CSG, as well as results of research and 
communication activities. LEV is distributed 
among 1.000 people, including life and social 
scientists, policy-makers, journalists and 
representatives of NGO’s and industry.
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valoRiSation ReSultS PeR 
PRoGRaMMe
Programme 1
Genomics applications
The societal value of programme 1 is most easily 
and directly demonstrated by its societal output 
in the form of publications and appearances for 
professionals and wider publics. Findings and 
reflections from projects on e.g. prenatal and 
preconception screening, whole genome analysis, 
animal experiments, have been presented in 
articles and interviews in several Dutch quality 
newspapers. 
Among the highlights is a monitoring report 
presenting an ethical exploration of the ‘thousand 
dollar genome’, written by two senior researchers 
involved in the CSG project on this topic. While 
being a thoroughly peer-reviewed academic 
publication partly based on the CSG project, 
the report presents a fine example of the societal 
utility of CSG research: it has been commissioned 
by the Dutch Health Council, received ample 
attention in several national newspapers and is 
expected to be guiding for future policy discussion 
and political debate. 
The long term investments in public and policy 
debates on screening by several researchers active 
in programme 1 resulted in a book reporting on 
a Witness Seminar with key actors in several 
decades of Dutch screening practice and policy. It 
has been one of many activities in a long process, 
in which the advice of the Dutch Health Council 
on newborn screening on cystic fibrosis is a recent 
result. The advice contributed to the decision (Nov 
2010) to start CF screening countrywide by 1st May 
2011. In two projects, CSG researchers produced 
internal reports for the Health Care Insurance 
Board (CVZ), on the consequences of genomics 
for the health care. (Detmar/ Janssens/ Cornel in 
2009; Broerse/ Toom in 2010) These debates may 
lead to funding of innovative initiatives.
The principal investigators of programme 1 
provide good examples of societal valorisation. 
One of them, Guido de Wert, has been one of the 
authors of the previously mentioned report for the 
Health Council, and has featured prominently in 
the various products of media attention about that 
report, as well as about the various other ethical 
issues addressed in programme 1. The other, 
Martina Cornel, has been nominated for the 
Societal Impact Award at her university in 2009. 
For programme 1, her membership of the Dutch 
Forum for Biotechnology and Genetics is one 
among several ways in which findings from the 
project find their way into policy discussions and 
vice versa. Together with Isa Houwink (researcher 
in CSG programme 3), in 2010 Cornel won 
the CSG valorisation award for “putting plans 
to action” to add cardiogenetics, especially of 
sudden cardiac death, to the general practitioners 
guidelines. Principal investigators Guido de Wert 
and Martina Cornel show international leadership 
in their positions in the European Society of 
Human Reproduction and Embryology resp. the 
European Society of Human Genetics.
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Many of the projects on medical genomics 
developments and issues in programme 1 are also 
part of the societal programme of the Centre of 
Medical Systems Biology (MAG-CMSB), which 
aims to investigate the potential implications of 
genetic testing for the quality of life, with the 
inclusion of individual privacy and responsibility. 
Other projects in the programme are carried out 
in the context of (or in close collaboration with) 
the Kluyver Centre, the Centre for BioSystems 
Genomics and the Netherlands Consortium for 
Healthy Ageing.
Besides in societal output and organisational 
links with NGI Centres, the societal value of 
programme 1 is manifest in the interactive 
approach that is typical for all CSG research. A 
core characteristic for this approach is the active 
and regular involvement of scientists and other 
stakeholders (e.g. health care professionals and 
policy makers) in various phases of the research 
process. In programme 1, interactions that 
contribute to the societal value of research are 
visible in various research activities and roles. 
Some researchers are able to use their professional 
background (as e.g. metabolic paediatrician or 
midwife) not merely for access to their field of 
study, but also as a source to check the practical 
validity and value of their preliminary results. 
Thus their own double position as researcher and 
(former) professional serves as an instrument for 
the societal valorisation of their projects.
In several other projects, actors in a particular 
field of study have not merely been involved 
as research informants, but also as prospective 
users or beneficiaries of research outcomes, 
by functioning as audiences for preliminary 
research results. The researcher in the project 
on biobanking governance, for example, has 
been invited by FEDERA (Dutch federation 
of biomedical scientific societies) to provide 
comments on a draft for a policy paper on the 
use of tissue for scientific research, as input 
for ongoing policy discussion about the code 
of conduct for good use of human tissue. His 
comments were highly appreciated and taken 
up in the further writing process. Preliminary 
results of projects on whole genome screening 
and analysis have also found their way into 
policy discussions (working document for the 
development of guidelines of the Dutch Society 
for Clinical Genetics on WGS-A; workshop of 
the Professional and Public Policy Committee 
of the European Society of Human Genetics, 
aiming at adequate guidelines for dealing with 
‘unexpected findings’). 
In a number of projects, including those on 
virology and preventive genomics, expert and 
stakeholder meetings have taken place that 
have provided input for research as well as a 
platform for discussion about preliminary results. 
Overall, researchers in the programme succeed 
in engaging prestigious experts (from within 
and beyond NGI), influential stakeholders and 
surprising public perspectives in their research 
activities.
Programme 2
Genomics agenda
The societal value of programme 2 is not so much 
to be found in the public arena, but more in close 
interactions with those responsible for research & 
development policies in a broad sense. 
CSG is currently preparing an international 
expert workshop on Intellectual Property (IP) 
policies, with a focus on alternatives to the 
current schemes that tend to narrow societal value 
down to patents and IP rights. The workshop 
will involve experts and representatives from 
life sciences, social sciences and humanities. A 
follow-up will be organised to involve policy and 
industry. This workshop will be used to present 
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and put to the test in a deliberative manner the 
preliminary results of six CSG projects. 
A number of CSG projects are a source of 
inspiration and input for education to life sciences 
students. This notably goes for bioinformatics 
students (Bioinformation and identity) and life 
sciences students (Genomics novels as test-beds). 
While the former course focuses on what it means 
to see life sciences in general and genomics in 
particular as an information science, the latter 
course empowers future life sciences researchers 
to employ novels as tools for reflection on 
epistemological and societal dimensions of their 
field.
As was already indicated above, a number of 
CSG projects function as sources of inspiration 
and input for education to life sciences students, 
on the bachelor level (philosophical and societal 
dimensions of genomics), the master level and 
the PhD level. Notably the project Epistemological 
Profile and Societal Prospects of Ecogenomics 
(contributes to master courses on bioethics and 
environmental ethics (Radboud University) and 
to PhD courses on ecogenomics (SENSE Research 
School, Wageningen University). Moreover, the 
annual meetings of the Ecogenomics Consortium 
and the Netherlands Ecogenomics Network 
are used as a podium to present and expose 
preliminary assessments to the field, inviting 
ecogenomics experts to comment on the findings.
In the context of the project How to overcome the 
10/ 90 gap in genomics research agendas? a weblog 
was developed on global justice as input to the 
project and as a contribution to the visibility of 
the project and the ongoing debate on this topic. 
Researchers active in projects on Genomics, 
Intellectual Property Regime and Global Justice 
Participation have also participated in the TV 
programme Labyrint on synthetic biology (April 
21, 2010).
Through workshops organised in the context of 
the research, professionals are actively involved 
in assessing the impact of genomics in their fields, 
ranging from asthma research (project Future 
scenarios in public health) up to education research.
The project Designing ‘good’ food has had a 
noticeable impact on strategic decision making 
processes concerning R&D within the company 
involved (Unilever). An interview with the 
head of R&D at Unilever for instance revealed 
that interactions between CSG researchers and 
Unilever staff (directly and through publications) 
have influenced the prioritisation of a number 
of basic research endeavours with Unilever 
R&D and that R&D managers have responded 
enthusiastically to this change.
CSG has organised a number of lectures and 
meetings with stakeholders in society and policy 
on the societal prospects of ecogenomics such as 
COGEM (Netherlands Committee on Genetic 
Modification) and the Louis Bolk Institute 
(Institute for international advice and research on 
sustainable agriculture, nutrition and health care).
“Interactions between csg 
research and Unilever 
staff have influenced the 
prioritisation of company 
research” 
John Verbakel, former head Unilever Research
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Programme 3
Communication and education
Many research projects of programme 3 have 
interaction, education and communication 
activities if CSG itself as their objects. The 
societal value of these projects is thus directly 
connected to enhancing the quality and/ or reach 
of these activities. 
As part of the project Talking Genomics, PhD 
researcher Koen Dortmans has organised a series 
of three public debates in debating centre LUX 
in Nijmegen in 2008. Under the heading ‘The 
preprogrammed human (De voorgeprogrammeerde 
mens)’ invited scientists, professionals, 
stakeholders, journalists and members of the 
audience were engaged in a collective search for 
answers to questions like: what does scientific 
research on genes and behaviour yield, and 
for whom? Which societal concerns are raised 
or addressed by such research? The debates 
attracted full houses. They were followed-up by 
a qualitative evaluation (survey and interviews), 
showing the relevance of the issues under debate.
The value of the project Situated Interactions partly 
concerns its contribution to the general research 
policy of the CSG and its implementation. A 
preliminary result of the project has been the 
operationalisation of the notion of ‘societal 
interaction’ in the format for proposals for CSG 
Next research projects. This was facilitated 
by the combined position of Maud Radstake 
as researcher on this project and as CSG staff 
member. This result has also provided valuable 
input for the selection and organisation of themes 
in activities for CSG researchers, including CSG’s 
scientific conferences, its annual researchers’ 
meetings (with lectures and exercises to enable 
reflection on the role and position of researchers 
vis-à-vis genomics scientists and societal 
audiences) and various workshops and meetings 
in individual projects (e.g. about societal learning 
and about asthma research) and for the CSG Next 
Self-Evaluation. 
CSG coordinates the DNA-labs on the Road. 
CSG’s aims for 2008-2012 are:
-  To improve the educational quality of the labs;
-  To articulate teacher’s demand;
-  To stimulate positive publicity about the labs;
-  To ensure the embedding of the labs after 
2012.
The quality of the lab has been improved by 
developing labs at two levels (basic and expert) 
and by improving and adding introductory and 
societal teaching modules. This was done in close 
cooperation with the coordinators of the five labs 
and with experts from CSG’s educational research 
programme (form the projects Towards a strategy 
for embedding Genomics literacy in science education 
and Educating for visual literacy in a genomics world: 
fostering imagery of cellular and molecular dynamics 
in science education). In addition, a sixth lab was 
developed on DNA-forensics, in cooperation 
with the Forensic Genomics Consortium and 
the University of Amsterdam, as it was clear that 
teachers show a great interest in forensics. 
On a regular basis, the DNA-labs receive 
attention in media aimed at science teachers 
and biologists, such as NVOX and Bionieuws. 
In addition, the labs have been in the daily 
newspapers. CSG’s magazine LEV as well as NGI 
societal Interface group
counsels cbsg management
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media increases the labs’ visibility among policy-
makers, NGO’s and industry. All labs actively 
engage in activities to ensure their continuity. 
The Wageningen and Utrecht DNA-labs have 
become a major activity in BSc education at 
these universities. The Delft lab is embedded 
in the Delft science centre. The Nijmegen lab 
(bioinformatics) can also be taught with limited 
assistance. The forensic lab is also taught at the 
police academy. An experiment with paid labs has 
started in 2010. 
In 2005, the Centre for BioSystems Genomics 
(CBSG) has installed a soundboard group with 
representatives from society, the so-called Societal 
Interface Group (SIG). Plans and strategies 
of the CBSG are submitted to the SIG. The 
group consists of persons who, by virtue of their 
profession, are involved in the production, 
preparation and experience of food, such as chefs, 
farmers and taste experts, as well as innovation 
experts, journalists and trend watchers. An 
evaluation of the SIG concluded that it is a 
potentially good instrument for the CBSG 
management, but that the design of its operations 
can be improved. Based on the recommendations 
of the evaluation study a second advisory round of 
the SIG has started in 2010. 
In March 2010, CSG organised a competition 
amongst its researcher to come up with concrete 
projects to implement their project results. 
The winning idea – stemming from the project 
‘Developing training in genetics/ genomics for primary 
health care workers’ was the devise of a guideline 
for general practitioners about the hereditary 
aspects of cardiovascular diseases. Within six 
months, the researcher has succeeded not only 
in drafting the guidelines – it has been actually 
taken up in the ‘Guideline Cardiovascular Risk 
management’ of the Dutch Association for 
General Practitioners. 
In January 2011 dr Daan Schuurbiers, who 
obtained his PhD on a project in the CSG I 
programme, was employed as a member of the 
CSG staff for the performance of a feasibility 
study for the commercial exploitation of methods 
and results from his own and other CSG projects. 
Co-applicant for the application for funding this 
project from the CSG Next valorisation budget 
was dr Maud Radstake, project leader and senior 
researcher in programme 3 and member of the 
CSG Next management team. The idea and 
model underlying the proposal has also been 
based on the preliminary results of her study on 
interactive ELSA. The proposal resulted from a 
collaborative effort by Radstake and Schuurbiers 
to participate in the NGI Venture Challenge, a 
competition for aspiring entrepreneurs. Chretien 
Herben, valorisation manager at NGI, is member 
of the advisory board for this project.
Researchers of CSG i
Where are they now?
Another way of looking at dissemination of CSG 
knowledge is to follow the careers of former CSG 
researchers. Most of them are still working in 
an academic surrounding. CSG has been able to 
retain some of the CSG I researchers for the CSG 
Next programme. Others have left the field of 
ELSA genomics as such but now occupy research 
positions in fields adjacent to ELSA research. 
project Sport, genetic and prevention
  Arno Muller is junior professor at the 
Universität Bielefeld, Abteilung für 
Sportwissenschaft.
project Empowering scientists in their societal 
responsibilities
  Daan Schuurbiers defended his thesis 
‘Social Responsibility in Scientific 
Practice’ in November 2010. On 1 January 
2011 he started a one year project at CSG 
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in which he explores ways to valorise the 
findings of his PhD research. 
project Ethics of nutrigenomics
  Rixt Komduur is researcher at the 
National Centre for the Studies into 
Alternatives to Animal Testing (Utrecht 
University).
project Towards a new model of public perception
  Renske Pin obtained her PhD in May 
2009, and is now researcher at TNO 
Quality of Life.
project Always expect the unexpected - legal and 
social aspects of communicating results from 
research on DNA-banks
  Jasper Bovenberg is attorney at law 
and independent consultant, and is still 
frequently consulted for life sciences.
project Telling tales
  Frans Meulenberg is research associate 
ethics and fiction at the department 
of Medical Ethics and Philosophy 
of Medicine, Erasmus University 
Rotterdam and researcher in the CSG 
Next project ‘Ageing: personalised 
genomics, empowerment, identity and 
medicalisation’.
project Reshaping criteria for screening in the age of 
genomics
  Carla van El is researcher at the Institute 
of Health Care Research, VU University 
medical centre Amsterdam and supervisor 
of the CSG project ‘A wealth of data’. 
project Plant genomics and interactive food supply 
chain management
  Josette Jacobs is assistant professor at the 
Faculty of Social Sciences, department 
of Methodical Ethics and Technology 
Assessment, Wageningen University 
Research Centre. 
project Mental illness, genomics and society
  Ingrid Baart is assistant professor at 
Metamedica, Free University Medical 
Centre, Amsterdam.
project Ethics of benefit-sharing in the field of plant 
genomics
  Bram de Jonge is postdoctoral researcher 
at Wageningen University & Research 
Centre. From 1 May 2011 he will carry 
out an 8 month project for CSG entitled 
‘Valorisation across borders’.
project Genomics-based Convergence of Food 
and Health Care: Changing Governance 
Arrangements
  Tilo Propp is researcher at the Rathenau 
Institute.
project Benefits and risks of cancer genomics for 
society
  Stephen Snelders is researcher and lecturer 
at Metamedica, VU University Medical 
Centre Amsterdam.
project Interactive scenario study of future 
developments in community genetics
  Erwin van Rijswoud is PhD researcher at 
the Institute for Science, Innovation and 
Society, Radboud University Nijmegen.
project DNA-labs for citizenship - Learning for 
understanding and valuing genomics in 
upper-secondary education
  Roald Verhoeff is assistant professor in 
Science Communication at the Institute 
for Science, Innovation and Society, 
Radboud University Nijmegen.
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project The future of ELSA genomics
  Peter Stegmaier is assistant professor 
Science, Technology and Policy Studies at 
the University of Twente.
project Imagining Genomics
  Cor van der Weele was postdoc researcher 
in CSG Next; after finishing her project 
she took up a project on in vitro meat, 
sponsored by the ministry of Economic 
Affairs.
  Ellen ter Gast is free lance consultant and 
guest lecturer at Leiden University.
project Genomics for the poor
  Edwin Nuijten is postdoc researcher at the 
Technology and Agrarian Development 
Group at Wageningen University & 
Research Centre.
The whereabouts of Jeanette Simmonds (project: 
Fueling debate) and Johan de Jong (project: 
Genetics of alcoholism) are unknown.
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Interlude
Extended SWOT Analysis
In this section an extended overview is provided of the Strengths, Weaknesses, Opportunities and 
Threats of the CSG Next programme. This will be used in chapter VI to answer the questions posed 
at the beginning of this report.
I.  Quality and Relevance
I.1.  Management of the research programme
Strengths Weaknesses
The programme consists of a portfolio of innovative high quality 
projects, assessed by Programme Committee and Scientific 
Advisory Board, monitored by Principal Investigators, and for the 
most part yielding good or even fascinating results. The size of 
the programme brings added value to individual projects.
Although our research is assessed and monitored, and problems 
are signalled and discussed with project managers, instruments 
to really influence progress and quality of research projects at 
various universities are limited.
opportunities threats
Due to the involvement of a relatively large number of research 
groups, we profit from a broad range of expertise and develop a 
solid research network on a national scale.
Competition between universities forces them to focus on their 
local profile at the expense of national programmes such as 
CSG.
Strengths Weaknesses
Sufficient funding and expertise for developing a communication 
programme in close interaction with research. Focus is 
important, for instance our decision to focus our public website 
on high school pupils in combination with mobile DNA-labs. 
The concept of genomics is complex for societal 
communication and as such is not always high-ranking on 
media and policy agendas.
opportunities threats
Interest in communication and interaction has increased among 
scientists and policy makers and funding agencies. Interest 
in genomics (e.g. personalised genome) seems to increase as 
well. More use could be made of new media opportunities for 
innovative forms of public engagement.
Limited attention and incentives for communication in 
academia (focus on academic performance) notably when it 
comes to long-term embedding and performance assessments.
I.2.  Quality of communication and interaction
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I.3.  Visibility
II.2. Acquisition
Strengths Weaknesses
As a research centre rather than a programme (employing open 
calls), we are in the position to present outcomes of projects or 
thematic clusters to policy and media in a recognisable fashion 
as CSG-output. Highly successful bi-annual international 
conferences area an indicator for international academic 
visibility. CSG researchers work on “hot topics” relevant for 
media and policy such as virology, animal testing, personalised 
genome sequencing, patenting, genes and behaviour, screening 
(preconception, prenatal, early born, ethnic groups), R&D and 
industrial innovation, role of experts in public dialogue.
A large part of CSG projects are performed by PhDs. It takes 
time to produce results that will attract attention outside 
academia. So far, take-up of results by policy makers has been 
limited. Too often, moreover, CSG researchers appearing in 
media and policy are not explicitly presented or recognisable as 
such.
opportunities threats
High expectations on economic and societal value of the 
life sciences. CSG should be able to add nuances and new 
perspectives. 
Tendency for policy and media to focus on specific findings 
rather than on CSG as a research centre. They are more 
interested in clear-cut messages and one-line recommendations 
rather than in scholarly analysis and nuance. Genomics remains 
a difficult concept for various stakeholders even in professional 
circles to deal with.
II.  Vitality and profile
II.1.  Funding
Strengths Weaknesses
The NGI funding is quite substantial and competitive (on an 
international level). The budget is sufficient to realise our 
ambitions and objectives.
Our dependence on one principal source of funding is a 
weakness, as this will expire after 2013. 
opportunities threats
The prospect that NGI funding will expire has stimulated a 
strategy for embedding CSG and developing new partnerships 
based on co-funding of promising themes (“Building blocks”).
Universities are likely to be faced with yet another round of 
substantial budget cuts. This threatens prospects for future 
funding and embedding.
Strengths Weaknesses
The acquisition of a major grant from NGI, unprecedented in our 
field in terms of size, and based on track record, midterm review 
and peer review, was a major feat.
Due to the size of NGI funding and the expectations and 
responsibilities involved in managing such a huge programme, 
the focus has been more on developing and monitoring the 
current programme than on developing additional sources of 
funding.
opportunities threats
Playing an active and at times leading role in international 
acquisition opportunities notably on the EU level (summit 
meetings, position papers, participation in projects and 
workshops of other programmes).
As CSG already receives sufficient funding, we are not ‘top 
priority’ when it comes to allocating funding from alternative 
sources. Mainly for this reason, additional acquisition activities 
on the national level have not always been successful.
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Strengths Weaknesses
Genomics is a broad and intriguing field of exceptional 
importance, both from a scientific and from a societal 
perspective, an exemplification of profound changes that are 
currently taking place in scientific research on an international 
scale.
There evidently has been an element of hype and 
overpromising at play in genomics research. CSG could be 
‘accused’ of too much identifying with this hype. 
opportunities threats
Building on our experiences with genomics, we may now 
employ the networks, toolboxes and expertise we have 
developed to newly emerging fields, with a special sensitivity 
even to the dynamics of hype and overpromising that is involved 
in these newly emerging areas of research as well.
Because of our involvement in the genomics endeavour, we 
are likely to be identified with this particular field. Now that 
genomics has become firmly embedded in the life sciences (and 
for that reason being less distinguishable as a specific area or 
approach) whereas new developments are emerging, we have 
to broaden our scope to address other emerging life sciences.
II.4. Focus
II.3. Profile
Strengths Weaknesses
We have established a recognisable profile as a research 
centre with our approach of interdisciplinarity, proximity and 
interaction. This furthers relevance, quality and visibility of 
our work. The combination of social sciences and humanities 
research with intense interaction with scientific and societal 
stakeholders constitutes a core element of our brand.
Our own field of research is difficult to define. Even the 
concept ELSA genomics research seems to have passed its 
expiration date in some circles, notably on an international 
level, where ELSA is now often identified with a very specific 
research strategy (more oriented towards embedded problem-
solving than towards reflection).
opportunities threats
We believe that on the basis of our profile as outlined we have 
become an interesting partner for future collaborations when it 
comes to studying the societal dimensions of the life sciences in 
an interactive manner both on a national and on an international 
level.
To establish a recognisable profile remains an important 
issue of concern in view of persistent tendencies of other 
parties to reduce our identity to a one-dimensional one, for 
example by seeing us solely as a research centre, or solely as a 
communication centre, or solely as a service provider the NGI 
network, or simply as a funding agency.
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Strengths Weaknesses
During the past six years we have been able, not only to 
develop an impressive set of research projects, but also to 
develop a research community of committed and talented early 
stage researchers devoted to collaboration, mutual learning 
and exchange. Besides academic research, they are trained 
in interaction and valorisation activities as well. This pool of 
researchers can be used for future research endeavours.
Although our research community consists of a relatively 
large number of PhD researchers on the one hand and 
of a number of key players (principal investigators and 
other project managers) on the other, we have noticed 
an underrepresentation of the intermediary level of senior 
researchers and junior tenured staff in the activities of our 
centre.
opportunities threats
CSG research not only provides on-site learning opportunities 
for (early stage) researchers, but also builds a network of former 
CSG researchers who migrate into other domains (policy, 
intermediary organisation, other research environments and the 
like), thus bringing the CSG ‘message’ further.
As a rule, master students are not well-prepared for our type of 
research. Deficits in knowledge and skills have to be acquired 
through on-site training. 
III. Viability
Strengths Weaknesses
We are moving into new, promising areas of research such 
as bio-based economy and personalised medicine. We are 
developing (through building blocks and valorisation projects) 
new collaborations with strategic partners such as BE-Basic, 
TIFN, Unilever and DSM.
The concept of ELSA genomics research seems to have passed 
its expiration date and has attracted a number of problematic 
connotations: considered as highly instrumental by some (SSH 
scholars) and as irrelevant by others (policy).
opportunities threats
It is expected that research and interaction concerning the 
societal dimensions of the life sciences remains important in the 
future and that a centre like CSG constitutes an obvious and 
experienced partner for this type of activities.
While funding opportunities are decreasing, the number 
of competitors (also learning from and building on our 
experiences and results) has increased. Moreover, there is a 
major tension between our own strategies for developing and 
embedding our research and our organisation on the one hand 
(building a national centre and an international network) and 
opportunities for acquisition (that still focus on competition 
between local universities rather than encouraging national 
platforms for research).
III.2. Embedding
III.3. Future research
III.1. Human resources
Strengths Weaknesses
We are developing a network of researchers and research 
partnerships on the local, national and the international level. 
PIs represent strong and experienced research groups and often 
occupy strong positions in the life sciences field. 
Whereas most departments and research groups involved in 
our programme have developed viable prospects for the future, 
some groups are clearly under pressure of local budget cuts 
opportunities threats
Building on our expertise, collaborations and networks we 
managed to develop so far, we are currently developing a 
strategy for the continuation of our activities in the future.
CSG as a national network will remain dependent on primary 
funding.
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In Chapter 1, three basic questions were posed: 
1.  How and to what extent have the objectives 
and ambitions of the CSG Next programme 
been realised? (quality and relevance)
2.  How and to what extent has CSG developed a 
distinctive profile for ELSA genomics research 
and societal interaction? (vitality)
3.  How and under which conditions can and 
should the work of CSG be continued? 
(viability)
This chapter provides the preliminary (midterm) 
answers to these questions. It consists of two parts. 
On the basis of the SWOT-analysis, our three 
questions will be explicitly addressed (6.1). For 
quality and relevance (Q1) as well as for vitality and 
profile (Q2) we will build on and summarise the 
analyses as presented in previous chapters. We 
then (6.2) will focus on the viability of a future 
programme for research and communication on 
the societal dimensions of emerging life sciences 
(Q3). 
6.1  Quality and vitality –  
a preliminary assessment
Q1: How and to what extent have the 
objectives and ambitions of the CSG next 
programme been realised? (quality and 
relevance)
We have developed a mechanism for quality 
assessment of projects that provides the 
conditions for achieving quality in our work and 
developing a recognisable profile (Section 2.1).
All three programmes yield results that are (a) 
relevant for genomics researcher and society and 
(b) combine proximity and collaboration with 
the scholarly roles in terms of addressing critical 
issues and outlining broader horizons (Section 
2.2). Moreover, we have managed to converge 
and cluster our research into a number of 
promising themes, that are relevant both from an 
academic and from a societal perspective (Section 
2.3), while our work contributes significantly 
to national and international scholarly debates 
on ELSA genomics (Section 2.4). Also, we 
may conclude that our research programmes are 
productive (Chapter 3), that we have developed 
a portfolio of targeted activities in the sphere 
of communication, education and interaction 
(Chapter 4) and have made significant progress 
when it comes to the societal valorisation of our 
work (Chapter 5). 
At the same time, we still have a challenging 
agenda for the years to come. First of all, 
although our research produces relevant and 
often intriguing results, uptake by policy makers, 
professionals and media of our findings is still 
limited. As we are now entering the years of 
harvest, the visibility of our outcomes must 
rank high on our agenda. Moreover, although 
we have achieved international prominence 
through our research, as indicated by for instance 
by performance indicators such as invited 
lectures, presentations at academic meetings, 
the organisation of international conferences 
as well as our role in reflection and exchange 
concerning the future agenda of ELSA life 
sciences, our leadership in developing EU projects 
has been limited so far. As indicated, this was 
due predominantly to the high demands involved 
in developing and monitoring our current 
programmes. Nonetheless, for the years to come, 
this (in combination with boosting visibility) will 
be a top priority for the coming years, notably as 
some of the themes we address are high potentials 
for the international agenda as well.      
Q2: How and to what extent has CSG 
developed a recognisable profile for 
elSa genomics research and societal 
interaction? (vitality and profile)
The CSG Next programme builds on a core 
idea, namely that both quality and relevance of 
Chapter 6
Quality, vitality and viability
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Major Strengths Major Weaknesses
1. Proximity to life science research
2.  CSG-partners in the life sciences and (potential) societal users 
of life science knowledge think highly of our work
3.  (Inter)national academic visibility (publications, invited 
lectures, conferences, networks)
4.  Substantial body of well-trained and committed researchers 
with interdisciplinary expertise and experienced in interactive 
research in various ‘hot topics’ in life science and society
1.  Risky entanglements with genomics researchers and other 
stakeholders than may endanger (perceived) independency 
and credibility 
2.  Various stakeholders (NGI, universities, policy, media, 
societal organisations, business) have diverging expectations 
concerning the objectives of our work. Although these 
expectations cannot be ignored, we have to keep our own 
focus and mission in mind. Not all expectations can be met
3. Relation with politics and policy is far from intense
4. Limited involvement of junior tenured staff
Major opportunities Major threats
1.  Acknowledgement of importance of social research and 
interactions for sustainable embedding of life sciences 
2.  Life sciences, agro-food, energy and high-tech materials 
remain priority areas for economic development 
3. Leading role in developing European networks
1. Major decrease of funding opportunities 
2.  (perceived) tension between quality (long-term focus) and 
relevance (results for policy and media) 
3.  Little familiarity with and low appreciation of societal research 
by life scientists outside our network
4.  Academic curricula do not sufficiently equip scientists and SSH 
scholars for interactive ELSA research
our research increase when performed in close 
collaboration with genomics researchers and 
societal stakeholders. Thus, the combination 
of academic research with communication, 
education, public dialogue and interaction is 
a central feature of the approach and profile of 
CSG Next, consisting of three basic elements: 
interdisciplinarity (among various social science 
and humanities disciplines), proximity (to life 
science research) and interaction (with societal 
stakeholders). We believe that this profile has not 
only developed into a recognisable CSG brand, 
but also furthered the robustness of our results. 
Nonetheless, a number of challenges have been 
identified as well. As our work is presented under 
the heading of ELSA genomics, it is a concern 
for us that on the one hand the ELSA concept 
seems to be out of fashion due to a number of 
denotations it has acquired, while genomics has 
become embedded to such an extent that it is now 
considered normal science by many, while new 
‘post-genomics’ fields such as synthetic biology are 
emerging. We have to consider an identity update, 
perhaps even a rebaptism into a ‘Centre for 
Society and Emerging Life Sciences’. Moreover, as 
indicated, there are still tensions between on the 
one hand the training early stage researchers have 
received as well as the type of activities and results 
acknowledged by academia on the one hand, and 
the CSG approach. Thus, as a rule, researchers are 
neither trained in interdisciplinary and interactive 
work, nor are they rewarded for trans-disciplinary 
activities and societal outreach. Thus, we have 
a role to play, in training early stage researchers 
for this type of work as well as in making 
academia more susceptible to the importance 
and complexity of societal performance and 
interdisciplinary collaboration.   
Finally, it is clear that CSG functions in a 
complex societal and academic environment 
and that we are confronted with diverging 
expectation as to what our centre should try to 
achieve. Building on our analysis so far, the major 
strengths, weaknesses, opportunities and threats 
for Q1 and Q2 can be summarised as follows.
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In the third section of this Chapter, building on 
these assessments, we will proceed to address Q3: 
should the work of CSG be continued and if so, 
how? (viability)
6.2  Viability and future prospects: 
CSG Next and beyond
Need and urgency
New and emerging techno-scientific research 
fields continue to emerge, giving rise to societal 
issues ranging from funding strategies and science 
governance via education and societal debate 
up to embedding novel applications in policy 
and professional practices. This calls, not for 
a set of problem-solving tools, but rather for a 
broad spectrum of opportunities for reflection 
and interaction in order to analyse, assess 
and improve the ‘landing’ of novel techno-
scientific developments in society and to identify 
and address emerging issues in a timely and 
transparent manner. In the years to come, an 
urgent need for the type of work we are currently 
involved in will persist. Moreover, our centre has 
become a skilled and respected potential partner, 
building on tangible experience and expertise, 
for addressing future developments. Since 
2004, much time and effort has been spent on 
developing and embedding the CSG as a national 
platform for research and interaction. Although 
CSG should be regarded as a tool, rather than as 
an end in itself, and although the continuation 
of CSG in the future is not a goal that should 
be pursued for its own sake, we are nonetheless 
convinced that there is a future role to play for 
CSG. Our strategy therefore should focus on 
safeguarding a future for the type of activities we 
are currently involved in.
Viability
Building on relevant high-quality research, 
CSG is well-positioned to respond to emerging 
opportunities. Research and interaction on society 
and the life sciences is situated along a continuum 
that stretches from knowledge production by 
means of critical analysis up to implementing and 
translating results in society. CSG constitutes 
the middle-ground of this continuum, inciting 
scholars accustomed to critical reflections ‘at a 
distance’ to become more intensively involved 
in interactive ways of working, while inciting 
researchers more oriented to problem-solving 
and implementation to envision the broader 
dimensions. Thus, we connect processes of 
academic knowledge production with various 
settings where this knowledge can be put to use. 
Both poles of the continuum are taken seriously. 
We must continue to produce high-quality 
academic knowledge relevant for society, but 
also create innovative options for presenting and 
testing our views in practice. Rather than serving 
dissemination, these settings serve as test-beds for 
assessing the quality and relevance of research, 
allowing stakeholders to actively contribute to 
the process of knowledge production. As a rule, 
this type of work is not funded through regular 
channels of research funding. Core funding, 
as part of a multiple-funding scheme based on 
acquisition and collaboration, remains necessary 
to develop and maintain a stable and coherent 
base of knowledge and skills that enables 
the connection between analysis and critical 
assessment on the one hand and application and 
communication on the other.
Embedding
Currently, the CSG Next programme is supported 
by a number of prominent research groups, 
firmly embedded in local research environments, 
representing vital networks and forms of expertise, 
with viable prospects for the future (see table 
below). Principal investigators indicated their 
willingness to continue to contribute to CSG as a 
national platform of research. 
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We are now developing new partnerships through 
building block-projects (co-funded by CSG 
and strategic partners in science and society) 
and by the establishing a network for European 
collaboration. In addition, CSG has recently 
organised a Stakeholder Dialogue aimed at 
involving many stakeholders in the development 
of our future agenda and creating a basis for a 
possible follow-up of CSG Next. There are a 
number of reasons why the CSG model has been 
worth the investments in terms of effort and 
funding:
1.  By encouraging experts from various research 
groups at various universities to join forces, 
our model assembles a sufficient range of 
interdisciplinary expertise to address complex 
issues (societal dimensions of emerging life 
sciences).
2.  Our model allows a team of experts to build 
on expertise, track records and networks 
developed in the context of past performance 
(both nationally and internationally) to take 
up novel challenges.
3.  Our model combines academic credibility of 
autonomous research with sufficient proximity 
and sensitivity to emerging and innovative life 
sciences.
4.  Our model bridges SSH research on the one 
hand and life sciences research on the other, 
addressing complex issues that call for input 
from various forms of expertise.
5.  Our model provides unique opportunities to 
combine societal research with interaction, 
involving a broad range of stakeholders (in 
industry, policy, civic society, public debate, 
journalism and the life sciences).
Participants of csg’s 
international scientific 
conference 
Amsterdam, May 2010
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Whereas the current programme is primarily 
funded by NGI, our future will be a multiple-
funding one, involving financial input from 
various local, national and international sources. 
Our current strategy of embedding of research 
activities and valorisation of results evolves on 
three levels:
1.  Local level
  A future CSG will be supported by prominent 
committed research groups (see table).
2.  International level
  CSG plays a leading role in establishing a 
European platform of centres and experts that, 
on the basis of a position paper, have agreed 
to join forces in order to (1) develop high-
quality proposals for open Calls (Framework 
Programmes, ERC, ESF, and the like);  
(2) provide input for strategic bodies as 
to future direction of research and (3) to 
strengthen our expertise and visibility for 
other stakeholders through joint activities 
such as publications, conferences and 
valorisation workshops.
3. National level
  Although after 2013 NGI will cease to exist, 
future programmes for stimulating promising 
emerging life sciences fields are bound to 
emerge. And as the Committee Bijker rightly 
argued in its report The Societal Aspects of 
the Life Sciences 2020, there can be no viable 
innovation in the life sciences without a 
proper ‘landing’ in society, as science and 
technology only function when they are 
socially well embedded. For an adequate 
embedding, research into the societal aspects 
of techno-scientific developments will 
continue to be necessary. In view of its unique 
expertise, networks and past performance, 
CSG has developed into an obvious partner 
for future actors active in this field to jointly 
develop novel interactive research efforts into. 
Strategic activities
In order to improve the prospects for a future 
CSG programme, the CSG management team 
and Programme Committee launched a strategy of 
developing so-called building-blocks. In the CSG 
Business Plan 2008–2012 we decided to reserve 
12% of our budget for future activities. In 2010, 
we began to invest in our future, strengthening 
the impact and visibility of our work and 
developing new themes and new strategic 
alliances on the other. We developed a series 
of ‘building blocks’, using funding of the CSG 
Next programme to build bridges towards a future 
CSG 3 programme. Thus, we began to build in a 
bottom-up manner a programme of collaborative 
research with key players in the life sciences arena 
(see table page 67).
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university Department / institute CSG Principal investigator
Delft University of Technology Biotechnology and Society Group (BTS) Prof Dr Patricia Osseweijer
VU University Amsterdam Athena Institute Dr Jacqueline Broerse
VU University Medical Centre Institute for Health and Care Research (EMGO) Prof Dr Martina Cornel
Maastricht University Department of Health, Ethics and Society (HES) Prof Dr Guido de Wert
Radboud University Nijmegen Institute for Science, Innovation & Society (ISIS) Prof Dr Hub Zwart
Wageningen University Department of Applied Philosophy Prof Dr Michiel Korthals
CSG’s committed research groups
Self-evaluation 2008-2010
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Short title Department Partners (strategic alliance / co-funding) embedding
1 Expectation management ISIS Platform Centres NGI National
2 Biomaterials as biosynthetic hybrids ISIS IMM CSB DSM (BMM) Local 
3 Towards the transparent embryo HES GROW (CTMM) Local
4 Dialogue as a tool for societal valorisation of ecogenomics Athena ) BE-Basic National
5 Engaging scientists in policy making for the bio-based 
economy 
BTS BE-Basic National
The collaboration with BE-Basic is highly 
significant, a model for similar initiatives in the 
future. BE-Basic is a new initiative, funded by FES 
(a government fund out of which large research 
consortia are funded) and building on previous 
NGI initiatives, notably the Kluyver Centre 
(Genomics of Industrial Fermentation) and the 
Ecogenomics Consortium. It aims to support the 
emergence of a bio-based, sustainable chemical 
industry with a budget of e 120 mln. Its societal 
programme led by prof Patricia Osseweijer aims 
to optimise the societal embedding of BE-Basic 
products while assessing socio-economic and 
sustainability issues and developing education, 
communication and societal valorisation 
programmes. Our agenda is not only developed 
in interaction with research institutes, however, 
but also with societal stakeholders, for instance 
through our stakeholder dialogue. Together 
with experts from society, policy and industry, 
we identified four urgent and relevant issues for 
research that are presently being developed. 
Our road map to preparing a future
We will take up the challenge to develop a future 
centre consisting of the following components:
1.  A mission with a broader scope (to analyse, 
assess and improve the conditions for societal 
embedding of emerging life sciences);
2.  A funding strategy based on a scheme of 
multiple funding (basic funding, acquisition 
and matching); 
3.  A joint programme of key research groups 
well-established at their various universities, 
building on the current network;
3.  Combining research with communication/
interaction on project and programme level 
4.  Collaborating with new large-scale initiatives 
in the life sciences in the new life sciences 
landscape such as BE-Basic;
5.  With core funding to be acquired from 
national funding bodies (either ministries or 
new innovation programmes) for management 
and communication, while research projects 
will be acquired through new innovative 
thematic programmes, matching and calls;
6.  SSH research projects developed by 
participating groups for which funding has 
been acquired are brought together in a 
common programme for collaboration and 
exchange;
7.  International projects acquired via teamwork 
in our international network.
This is a highly ambitious and as yet uncertain 
goal. Nonetheless, we ourselves can play an active 
role in preparing the ground and creating the 
conditions for such a strategy to be feasible.
‘Building blocks’, recently developed research projects
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